Staphylococcus aureus CIP 106414 is a facultative anaerobe, Gram-positive, coccus-shaped bacterium of the family Staphylococcaceae.
Gram-positive coccus-shaped facultative anaerobe genome sequence Bacteria| @ref 20215 |
Last LPSN update
2026-05-29 08:39:14 |
| Domain Bacteria |
| Phylum Bacillota |
| Class Bacilli |
| Order Caryophanales |
| Family Staphylococcaceae |
| Genus Staphylococcus |
| Species Staphylococcus aureus |
| Full scientific name Staphylococcus aureus Rosenbach 1884 (Approved Lists 1980) |
| Synonyms (2) |
| @ref | Spore formation | Confidence | |
|---|---|---|---|
| 125439 | 91.293 |
| @ref | Value | Activity | Ec | |
|---|---|---|---|---|
| 68382 | acid phosphatase | + | 3.1.3.2 | from API zym |
| 39523 | alcohol dehydrogenase | - | 1.1.1.1 | |
| 68382 | alkaline phosphatase | + | 3.1.3.1 | from API zym |
| 68382 | alpha-chymotrypsin | - | 3.4.21.1 | from API zym |
| 68382 | alpha-fucosidase | - | 3.2.1.51 | from API zym |
| 68382 | alpha-galactosidase | - | 3.2.1.22 | from API zym |
| 68382 | alpha-glucosidase | - | 3.2.1.20 | from API zym |
| 68382 | alpha-mannosidase | - | 3.2.1.24 | from API zym |
| 39523 | amylase | - | ||
| 68382 | beta-galactosidase | - | 3.2.1.23 | from API zym |
| 39523 | beta-galactosidase | - | 3.2.1.23 | |
| 68382 | beta-glucosidase | - | 3.2.1.21 | from API zym |
| 68382 | beta-glucuronidase | - | 3.2.1.31 | from API zym |
| 39523 | caseinase | - | 3.4.21.50 | |
| 39523 | catalase | + | 1.11.1.6 | |
| 39523 | coagulase | + | ||
| 68382 | cystine arylamidase | - | 3.4.11.3 | from API zym |
| 39523 | DNase | + | ||
| 68382 | esterase (C 4) | + | from API zym | |
| 68382 | esterase lipase (C 8) | + | from API zym | |
| 39523 | gamma-glutamyltransferase | - | 2.3.2.2 | |
| 39523 | gelatinase | - | ||
| 39523 | lecithinase | - | ||
| 68382 | leucine arylamidase | - | 3.4.11.1 | from API zym |
| 39523 | lipase | - | ||
| 68382 | lipase (C 14) | - | from API zym | |
| 39523 | lysine decarboxylase | - | 4.1.1.18 | |
| 68382 | N-acetyl-beta-glucosaminidase | - | 3.2.1.52 | from API zym |
| 68382 | naphthol-AS-BI-phosphohydrolase | + | from API zym | |
| 39523 | ornithine decarboxylase | - | 4.1.1.17 | |
| 39523 | oxidase | - | ||
| 39523 | protease | + | ||
| 68382 | trypsin | - | 3.4.21.4 | from API zym |
| 39523 | tween esterase | + | ||
| 39523 | urease | + | 3.5.1.5 | |
| 68382 | valine arylamidase | - | from API zym |
| @ref | Description | Assembly level | INSDC accession | BV-BRC accession | IMG accession | NCBI tax ID | Score | |
|---|---|---|---|---|---|---|---|---|
| 66792 | ASM101943v2 assembly for Staphylococcus aureus NRS1 | complete | GCA_001019435   | 1280.4808  | 2852001951  | 1280 | 98.86 | |
| Topic | Title | Authors | Journal | DOI | Year | |
|---|---|---|---|---|---|---|
| Fluoroquinolone Derivatives in the Treatment of Mycobacterium tuberculosis Infection. | Pais JP, Policarpo M, Pires D, Francisco AP, Madureira AM, Testa B, Anes E, Constantino L. | Pharmaceuticals (Basel) | 10.3390/ph15101213 | 2022 | | |
| Enzymology | Comprehensive Laboratory Evaluation of a Specific Lateral Flow Assay for the Presumptive Identification of Francisella tularensis in Suspicious White Powders and Aerosol Samples. | Pillai SP, DePalma L, Prentice KW, Ramage JG, Chapman C, Sarwar J, Parameswaran N, Petersen J, Yockey B, Young J, Singh A, Pillai CA, Manickam G, Thirunavkkarasu N, Avila JR, Sharma S, Morse SA, Venkateswaran K, Anderson K, Hodge DR. | Health Secur | 10.1089/hs.2019.0151 | 2020 | |
| Enzymology | Comprehensive Laboratory Evaluation of a Lateral Flow Assay for the Detection of Yersinia pestis. | Prentice KW, DePalma L, Ramage JG, Sarwar J, Parameswaran N, Petersen J, Yockey B, Young J, Joshi M, Thirunavvukarasu N, Singh A, Chapman C, Avila JR, Pillai CA, Manickam G, Sharma SK, Morse SA, Venkateswaran KV, Anderson K, Hodge DR, Pillai SP. | Health Secur | 10.1089/hs.2019.0094 | 2019 | |
| Enzymology | Comprehensive Laboratory Evaluation of a Highly Specific Lateral Flow Assay for the Presumptive Identification of Bacillus anthracis Spores in Suspicious White Powders and Environmental Samples. | Ramage JG, Prentice KW, DePalma L, Venkateswaran KS, Chivukula S, Chapman C, Bell M, Datta S, Singh A, Hoffmaster A, Sarwar J, Parameswaran N, Joshi M, Thirunavkkarasu N, Krishnan V, Morse S, Avila JR, Sharma S, Estacio PL, Stanker L, Hodge DR, Pillai SP. | Health Secur | 10.1089/hs.2016.0041 | 2016 | |
| Antimicrobial Activity and Potential of Olive Leaf Extract as a Topical Agent to Combat Staphylococcus aureus and MRSA Strains: An In Vitro Evaluation. | Clusa L, Latorre-Millan M, Milagro AM, Tristancho-Baro A, Lopez-Calleja AI, Garcia-Lechuz JM, Fortuno B, Del Villar N, Asensio M, Martin-Belloso O, Odriozola-Serrano I, Martinez-Beamonte R, Osada J, Rezusta A, Gilaberte Y. | Pharmaceuticals (Basel) | 10.3390/ph18091358 | 2025 | | |
| 2,4-Di-tert-butylphenol from Endophytic Fungi Fusarium oxysporum attenuates the growth of multidrug-resistant pathogens. | Sundar RDV, Arunachalam S. | Front Microbiol | 10.3389/fmicb.2025.1575021 | 2025 | | |
| Long-Chain Hydrocarbons in the Mucous Layer of the Galleria mellonella Insect Eggs as Potential Antibacterial Agents against Multidrug-Resistant Bacteria. | Luz LF, Nascimento GL, Volcan GN, Ligabue RA, Miranda GM, Trentin DS. | ACS Omega | 10.1021/acsomega.5c00938 | 2025 | | |
| Genetics | Genome-Guided Identification and Characterisation of Broad-Spectrum Antimicrobial Compounds of Bacillus velezensis Strain PD9 Isolated from Stingless Bee Propolis. | Puan SL, Erriah P, Yahaya NM, Ali MSM, Ahmad SA, Oslan SN, Baharum SN, Salleh AB, Sabri S. | Probiotics Antimicrob Proteins | 10.1007/s12602-025-10451-3 | 2025 | |
| Gallium Liquid Metal Nanoparticles as Agents to Treat Multidrug-Resistant Bacterial Infections. | Nguyen HT, Puangseree J, Nguyen TT, Nguyen MT, Leigh C, Venter H, Vasilev K, Chuanchuen R, Trott DJ, Truong VK, Ogunniyi AD. | Microbiologyopen | 10.1002/mbo3.70078 | 2025 | | |
| Anti-Staphylococcus aureus Activity of Volatile Phytochemicals and Their Combinations with Conventional Antibiotics Against Methicillin-Susceptible S. aureus (MSSA) and Methicillin-Resistant S. aureus (MRSA) Strains. | Nikolic I, Aleksic Sabo V, Gavric D, Knezevic P. | Antibiotics (Basel) | 10.3390/antibiotics13111030 | 2024 | | |
| Xenomyrothecium tongaense PTS8: a rare endophyte of Polianthes tuberosa with salient antagonism against multidrug-resistant pathogens. | Sundar RDV, Arunachalam S. | Front Microbiol | 10.3389/fmicb.2024.1327190 | 2024 | | |
| Molecular Differentiation and Detection of AMR Genes from Nosocomial Staphylococcus spp. | Carneiro I, da Silva WLP, de Souza Santos DR, de Filippis I. | Pathogens | 10.3390/pathogens14050403 | 2025 | | |
| Endophytic fungi of Tradescantia pallida mediated targeting of Multi-Drug resistant human pathogens. | Dhevi V Sundar R, Arunachalam S. | Saudi J Biol Sci | 10.1016/j.sjbs.2024.103937 | 2024 | | |
| New Bioactive Polyketides from the Mangrove-Derived Fungus Daldinia eschscholzii HJX1P2. | Yu M, Qiu Y, Chen S, Shi J, Gong X, Feng J, Lin F, Zeng W, Kang W, Zheng C, Huang G. | Mar Drugs | 10.3390/md23060238 | 2025 | | |
| Characterization of Brazilian green propolis as a photosensitizer for LED light-induced antimicrobial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-intermediate Staphylococcus aureus (VISA). | Ribeiro IS, Muniz IPR, Galantini MPL, Goncalves CV, Lima PHB, Silva ES, Silva NR, Rosa FCS, Rosa LP, Costa DJ, Amaral JG, da Silva RAA. | Photochem Photobiol Sci | 10.1007/s43630-023-00495-1 | 2023 | | |
| Detection of Vancomycin Resistance among Methicillin-Resistant Staphylococcus aureus Strains Recovered from Children with Invasive Diseases in a Reference Pediatric Hospital. | Pardo L, Mota MI, Parnizari A, Varela A, Algorta G, Varela G. | Antibiotics (Basel) | 10.3390/antibiotics13040298 | 2024 | | |
| In Silico Approach for Antibacterial Discovery: PTML Modeling of Virtual Multi-Strain Inhibitors Against Staphylococcus aureus. | Kleandrova VV, Cordeiro MNDS, Speck-Planche A. | Pharmaceuticals (Basel) | 10.3390/ph18020196 | 2025 | | |
| New Meroterpenoid Derivatives from the Pomegranate-Derived Endophytic Fungus Talaromyces purpureogenus. | Anwar A, Elnaggar MS, Elissawy AM, Ibrahim N, Mandi A, Kurtan T, Liu Z, El-Ahmady SH, Kalscheuer R. | Molecules | 10.3390/molecules28227650 | 2023 | | |
| Optimized Sambucus nigra L., Epilobium hirsutum L., and Lythrum salicaria L. Extracts: Biological Effects Supporting Their Potential in Wound Care. | Safta DA, Vlase AM, Pop A, Cherfan J, Carpa R, Iurian S, Bogdan C, Vlase L, Moldovan ML. | Antioxidants (Basel) | 10.3390/antiox14050521 | 2025 | | |
| Characterizing interactions of Staphylococcus aureus and Escherichia coli in dual-species implant-associated biofilms. | Sekar A, Ben Malick F, Deepak SU, Inverardi N, Murugesan D, Muratoglu OK, Oral E. | NPJ Biofilms Microbiomes | 10.1038/s41522-025-00754-2 | 2025 | | |
| Genetics | Complete genome sequence, metabolic profiling and functional studies reveal Ligilactobacillus salivarius LS-ARS2 is a promising biofilm-forming probiotic with significant antioxidant, antibacterial, and antibiofilm potential. | Patra S, Pradhan B, Roychowdhury A. | Front Microbiol | 10.3389/fmicb.2025.1535388 | 2025 | |
| Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. | Padalino G, Duggan K, Mur LAJ, Maillard JY, Brancale A, Hoffmann KF. | Microbiologyopen | 10.1002/mbo3.70011 | 2024 | | |
| Antibiotic resistance and beta-lactam resistant genes among bacterial isolates from clinical, river water and poultry samples from Kathmandu, Nepal. | Thapa Shrestha U, Shrestha M, Shrestha N, Rijal KR, Banjara MR. | JAC Antimicrob Resist | 10.1093/jacamr/dlaf186 | 2025 | | |
| Identification and determination of usnic acid and fatty acid from various lichen species in arequipa, Peru, as well as antibacterial and antioxidant capacity. | Carrasco F, Hernandez W, Castro N, Guerrero M, Tamariz-Angeles C, Olivera-Gonzales P, Echevarria-Rodriguez D, Raposo C, Silva LA, Rodilla JM. | Heliyon | 10.1016/j.heliyon.2024.e39703 | 2024 | | |
| Coumarin derivatives as new anti-biofilm agents against Staphylococcus aureus. | Wahab AT, Nadeem F, Salar U, Bilal HM, Farooqui M, Javaid S, Sadaf S, Khan KM, Choudhary MI. | PLoS One | 10.1371/journal.pone.0307439 | 2024 | | |
| Cannabinoids as Antibacterial Agents: A Systematic and Critical Review of In Vitro Efficacy Against Streptococcus and Staphylococcus. | Niyangoda D, Aung ML, Qader M, Tesfaye W, Bushell M, Chiong F, Tsai D, Ahmad D, Samarawickrema I, Sinnollareddy M, Thomas J. | Antibiotics (Basel) | 10.3390/antibiotics13111023 | 2024 | | |
| Agave amica (Medik.) Thiede & Govaerts (Asparagaceae)-Insights into Its Valuable Phenolic Profile and In Vitro Antimicrobial, Antibiofilm, Antioxidative, and Antiproliferative Properties. | Niculae M, Hanganu D, Oniga I, Burca SA, Tiperciuc B, Ielciu I, Pall E, Bab T, Burtescu RF, Sava MA, Benedec D. | Antibiotics (Basel) | 10.3390/antibiotics14070638 | 2025 | | |
| Seasonal and hospital settings variations in antimicrobial resistance among clinical isolates from cardiac patients: insights from a 7-Year study. | Asghar MU, Zaidi AH, Tariq M, Ain NU. | BMC Infect Dis | 10.1186/s12879-025-11171-3 | 2025 | | |
| Biocompatibility of Phosphorus Dendrimers and Their Antibacterial Properties as Potential Agents for Supporting Wound Healing. | Bielska B, Wronska N, Kolodziejczyk-Czepas J, Mignani S, Majoral JP, Waczulikova I, Lisowska K, Bryszewska M, Milowska K. | Mol Pharm | 10.1021/acs.molpharmaceut.4c01156 | 2025 | | |
| Fast Release of Carboxylic Acid inside Cells. | Moser P, Zelli R, Dos Santos LJ, Henry M, Sanchez-Garcia K, Caspar Y, Marro FC, Chovelon B, Saez Cabodevilla J, de Choudens SO, Faudry E, Wong YS. | ChemMedChem | 10.1002/cmdc.202500056 | 2025 | | |
| In vitro Antibacterial and Antifungal Activity of a Skin Ointment and Its Active Pharmaceutical Ingredients Larch Turpentine, Turpentine Oil, and Eucalyptus Oil. | Pianta E, Gunnewich N, Zimmermann C, Petrini O, Diaz-Miyar J, Fragoso-Corti C. | Skin Pharmacol Physiol | 10.1159/000543158 | 2025 | | |
| Discovery, characterization, and structure of a cofactor-independent histidine racemase from the oral pathogen Fusobacterium nucleatum. | Lamer T, Chen P, Venter MJ, van Belkum MJ, Wijewardane A, Wu C, Lemieux MJ, Vederas JC. | J Biol Chem | 10.1016/j.jbc.2024.107896 | 2024 | | |
| An Investigation of Virulence Genes of Staphylococcus aureus in Autologous Vaccines Against Sheep Mastitis. | Sezzi E, Fanelli R, Gobbi D, Scandurra P, Mannucci V, Usai I, Ragionieri G, Mezher Z, Fichi G. | Animals (Basel) | 10.3390/ani14223172 | 2024 | | |
| Diverse chemotypes of polyketides as promising antimicrobial agents: latest progress. | Kumar G, Chopra S. | RSC Adv | 10.1039/d5ra03414k | 2025 | | |
| Activity of aurisin A isolated from Neonothopanus nambi against methicillin-resistant Staphylococcus aureus strains. | Krishnasamy G, Azahar MS, Rahman SSA, Vallavan V, Zin NM, Latif MA, Hatsu M. | Saudi Pharm J | 10.1016/j.jsps.2023.03.002 | 2023 | | |
| Characterisation of in vitro resistance selection against second-/last-line antibiotics in methicillin-resistant Staphylococcus aureus ATCC 43300 strain. | Prasetyoputri A, Pitt ME, Cao MD, Ramu S, Kavanagh A, Elliott AG, Ganesamoorthy D, Monk IR, Stinear TP, Cooper MA, Coin LJM, Blaskovich MAT. | JAC Antimicrob Resist | 10.1093/jacamr/dlaf108 | 2025 | | |
| Research Progress on the Antibacterial Activity of Natural Flavonoids. | Zhang Z, Cao M, Shang Z, Xu J, Chen X, Zhu Z, Wang W, Wei X, Zhou X, Bai Y, Zhang J. | Antibiotics (Basel) | 10.3390/antibiotics14040334 | 2025 | | |
| Methicillin-Resistant Staphylococcus aureus (MRSA): Resistance, Prevalence, and Coping Strategies | Li J, Cheng F, Wei X, Bai Y, Wang Q, Li B, Zhou Y, Zhai B, Zhou X, Wang W, Zhang J. | Antibiotics (Basel) | 2025 | | ||
| Development of 4-[4-(Anilinomethyl)-3-phenyl-pyrazol-1-yl] Benzoic Acid Derivatives as Potent Anti-Staphylococci and Anti-Enterococci Agents. | Raj Kc H, Gilmore DF, Alam MA. | Antibiotics (Basel) | 10.3390/antibiotics11070939 | 2022 | | |
| Optimization and evaluation of a multiplex PCR assay for detection of Staphylococcus aureus and its major virulence genes for assessing food safety. | Nadiya S, Kolla HB, Reddy PN. | Braz J Microbiol | 10.1007/s42770-023-00906-6 | 2023 | | |
| N-Alkyl-2-Quinolonopyrones Demonstrate Antimicrobial Activity against ESKAPE Pathogens Including Staphylococcus aureus. | Moynihan E, Mackey K, Blaskovich MAT, Reen FJ, McGlacken G. | ACS Med Chem Lett | 10.1021/acsmedchemlett.2c00185 | 2022 | | |
| Efflux pump modulation by Montelukast and its roles in restoring antibiotic susceptibility in multidrug-resistant Staphylococcus aureus. | Ojha S, Sinsinwar S, Chatterjee P, Biswal S, Pradhan P, Beuria TK. | EBioMedicine | 10.1016/j.ebiom.2025.105658 | 2025 | | |
| Evaluation of Total Phenolic and Flavonoid Contents, Antibacterial and Antibiofilm Activities of Hungarian Propolis Ethanolic Extract against Staphylococcus aureus. | Bouchelaghem S, Das S, Naorem RS, Czuni L, Papp G, Kocsis M. | Molecules | 10.3390/molecules27020574 | 2022 | | |
| Synthesis and Antimicrobial Activity of 3D Micro-Nanostructured Diatom Biosilica Coated by Epitaxially Growing Ag-AgCl Hybrid Nanoparticles. | Bekissanova Z, Railean V, Wojtczak I, Brzozowska W, Trykowski G, Ospanova A, Sprynskyy M. | Biomimetics (Basel) | 10.3390/biomimetics9010005 | 2023 | | |
| The Antioxidant, Antibacterial and Cell-Protective Properties of Bioactive Compounds Extracted from Rowanberry (Sorbus aucuparia L.) Fruits In Vitro. | Aurori M, Niculae M, Hanganu D, Pall E, Cenariu M, Vodnar DC, Fit N, Andrei S. | Plants (Basel) | 10.3390/plants13040538 | 2024 | | |
| Pathogenicity | Preliminary Insight of Pyrrolylated-Chalcones as New Anti-Methicillin-Resistant Staphylococcus aureus (Anti-MRSA) Agents. | Gunasekharan M, Choi TI, Rukayadi Y, Mohammad Latif MA, Karunakaran T, Mohd Faudzi SM, Kim CH. | Molecules | 10.3390/molecules26175314 | 2021 | |
| Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors. | Roy S, Kc HR, Roberts J, Hastings J, Gilmore DF, Shields RC, Alam MA. | J Med Chem | 10.1021/acs.jmedchem.3c00969 | 2023 | | |
| A Novel Approach Based on Real-Time PCR with High-Resolution Melting Analysis for the Simultaneous Identification of Staphylococcus aureus and Staphylococcus argenteus. | Chieffi D, Bongiorno D, Licitra A, Campanile F, Fusco V. | Foods | 10.3390/foods13183004 | 2024 | | |
| Pathogenicity | In Vitro and In Vivo Antibacterial Activity of Gliotoxin Alone and in Combination with Antibiotics against Staphylococcus aureus. | Esteban P, Redrado S, Comas L, Domingo MP, Millan-Lou MI, Seral C, Algarate S, Lopez C, Rezusta A, Pardo J, Arias M, Galvez EM. | Toxins (Basel) | 10.3390/toxins13020085 | 2021 | |
| Antibacterial Activity of Arbutus pavarii Pamp against Methicillin-Resistant Staphylococcus aureus (MRSA) and UHPLC-MS/MS Profile of the Bioactive Fraction. | Buzgaia N, Awin T, Elabbar F, Abdusalam K, Lee SY, Rukayadi Y, Abas F, Shaari K. | Plants (Basel) | 10.3390/plants9111539 | 2020 | | |
| Pathogenicity | Rational design of balanced dual-targeting antibiotics with limited resistance. | Nyerges A, Tomasic T, Durcik M, Revesz T, Szili P, Draskovits G, Bogar F, Skok Z, Zidar N, Ilas J, Zega A, Kikelj D, Daruka L, Kintses B, Vasarhelyi B, Foldesi I, Kata D, Welin M, Kimbung R, Focht D, Masic LP, Pal C. | PLoS Biol | 10.1371/journal.pbio.3000819 | 2020 | |
| Antimicrobial Action Mechanisms of Natural Compounds Isolated from Endophytic Microorganisms. | Eshboev F, Mamadalieva N, Nazarov PA, Hussain H, Katanaev V, Egamberdieva D, Azimova S. | Antibiotics (Basel) | 10.3390/antibiotics13030271 | 2024 | | |
| Revealing the Phenolic Composition and the Antioxidant, Antimicrobial and Antiproliferative Activities of Two Euphrasia sp. Extracts. | Benedec D, Oniga I, Hanganu D, Vlase AM, Ielciu I, Crisan G, Fit N, Niculae M, Bab T, Pall E, Vlase L. | Plants (Basel) | 10.3390/plants13131790 | 2024 | | |
| Applications and Opportunities in Using Disulfides, Thiosulfinates, and Thiosulfonates as Antibacterials. | Blume L, Long TE, Turos E. | Int J Mol Sci | 10.3390/ijms24108659 | 2023 | | |
| Design, synthesis, and antibacterial activity of N-(trifluoromethyl)phenyl substituted pyrazole derivatives. | Saleh I, Raj Kc H, Roy S, Abugazleh MK, Ali H, Gilmore D, Alam MA. | RSC Med Chem | 10.1039/d1md00230a | 2021 | | |
| 1,2,3-Triazoles and their metal chelates with antimicrobial activity. | Todorov L, Kostova I. | Front Chem | 10.3389/fchem.2023.1247805 | 2023 | | |
| Characterization and Antibacterial Evaluation of Biodegradable Mannose-Conjugated Fe-MIL-88NH2 Composites Containing Vancomycin against Methicillin-Resistant Staphylococcus aureus Strains. | Haseena, Shah M, Rehman K, Khan A, Farid A, Marini C, Di Cerbo A, Shah MR. | Polymers (Basel) | 10.3390/polym14132712 | 2022 | | |
| Staphylococcus aureus coa gene sequence analysis can prevent misidentification of coagulase-negative strains and contribute to their control in dairy cow herds. | Locatelli C, Gattolin S, Monistero V, Castiglioni B, Moroni P, Addis MF, Cremonesi P. | Front Microbiol | 10.3389/fmicb.2023.1120305 | 2023 | | |
| Decrease in vancomycin MICs and prevalence of hGISA in MRSA and MSSA isolates from a German pediatric tertiary care center. | Haas K, Meyer-Buehn M, von Both U, Hubner J, Schober T. | Infection | 10.1007/s15010-023-02036-5 | 2023 | | |
| The limitless endophytes: their role as antifungal agents against top priority pathogens. | Moussa AY. | Microb Cell Fact | 10.1186/s12934-024-02411-3 | 2024 | | |
| Pathogenicity | Evaluation of the Antimicrobial Potential and Toxicity of a Newly Synthesised 4-(4-(Benzylamino)butoxy)-9H-carbazole. | Zawadzka K, Felczak A, Glowacka IE, Piotrowska DG, Lisowska K. | Int J Mol Sci | 10.3390/ijms222312796 | 2021 | |
| beta-Lactamase Suppression as a Strategy to Target Methicillin-Resistant Staphylococcus aureus: Proof of Concept. | Thomas PM, Deming MA, Sarkar A. | ACS Omega | 10.1021/acsomega.2c04381 | 2022 | | |
| Interaction of Rhus typhina Tannin with Lipid Nanoparticles: Implication for the Formulation of a Tannin-Liposome Hybrid Biomaterial with Antibacterial Activity. | Sekowski S, Naziris N, Chountoulesi M, Olchowik-Grabarek E, Czerkas K, Veiko A, Abdulladjanova N, Demetzos C, Zamaraeva M. | J Funct Biomater | 10.3390/jfb14060296 | 2023 | | |
| Cupressus sempervirens Essential Oil: Exploring the Antibacterial Multitarget Mechanisms, Chemcomputational Toxicity Prediction, and Safety Assessment in Zebrafish Embryos. | Akermi S, Smaoui S, Elhadef K, Fourati M, Louhichi N, Chaari M, Chakchouk Mtibaa A, Baanannou A, Masmoudi S, Mellouli L. | Molecules | 10.3390/molecules27092630 | 2022 | | |
| In-Depth Study of Thymus vulgaris Essential Oil: Towards Understanding the Antibacterial Target Mechanism and Toxicological and Pharmacological Aspects. | Akermi S, Smaoui S, Fourati M, Elhadef K, Chaari M, Chakchouk Mtibaa A, Mellouli L. | Biomed Res Int | 10.1155/2022/3368883 | 2022 | | |
| New N-phenylpyrrolamide inhibitors of DNA gyrase with improved antibacterial activity. | Cotman AE, Fulgheri F, Piga M, Persolja P, Tiz DB, Skok Z, Durcik M, Sterle M, Dernovsek J, Cruz CD, Tammela P, Szili PE, Daruka L, Pal C, Zega A, Masic LP, Ilas J, Tomasic T, Kikelj D, Zidar N. | RSC Adv | 10.1039/d4ra04802d | 2024 | | |
| Phenotype | Single-cell phenotypic profiling and backtracing exposes and predicts clinically relevant subpopulations in isogenic Staphylococcus aureus communities. | Hira J, Singh B, Halder T, Mahmutovic A, Ajayi C, Sekh AA, Hegstad K, Johannessen M, Lentz CS. | Commun Biol | 10.1038/s42003-024-06894-z | 2024 | |
| Comparing the Synergistic and Antagonistic Interactions of Ciprofloxacin and Levofloxacin Combined with Rifampin against Drug-Resistant Staphylococcus aureus: A Time-Kill Assay. | Kang YR, Chung DR, Ko JH, Huh K, Cho SY, Kang CI, Peck KR. | Antibiotics (Basel) | 10.3390/antibiotics12040711 | 2023 | | |
| Pathogenicity | Antifungal polyketide derivatives from the endophytic fungus Aplosporella javeedii. | Gao Y, Wang L, Kalscheuer R, Liu Z, Proksch P. | Bioorg Med Chem | 10.1016/j.bmc.2020.115456 | 2020 | |
| Metabolism | Harnessing the Dual Antimicrobial Mechanism of Action with Fe(8-Hydroxyquinoline)3 to Develop a Topical Ointment for Mupirocin-Resistant MRSA Infections. | Abeydeera N, Benin BM, Mudarmah K, Pant BD, Chen G, Shin WS, Kim MH, Huang SD. | Antibiotics (Basel) | 10.3390/antibiotics12050886 | 2023 | |
| Healing of Skin Wounds in Rats Using Creams Based on Symphytum Officinale Extract. | Marza SM, Daescu AM, Purdoiu RC, Dragomir M, Tataru M, Melega I, Nagy AL, Gal A, Tabaran F, Bogdan S, Moldovan M, Pall E, Munteanu C, Magyari K, Papuc I. | Int J Mol Sci | 10.3390/ijms25063099 | 2024 | | |
| Evaluation of New Antimicrobial Agents Based on tris(1H-Indol-3-yl)methylium Salts: Activity, Toxicity, Suppression of Experimental Sepsis in Mice. | Trenin AS, Isakova EB, Treshchalin MI, Polozkova VA, Mirchink EP, Panov AA, Simonov AY, Bychkova OP, Tatarskiy VV, Lavrenov SN. | Pharmaceuticals (Basel) | 10.3390/ph15020118 | 2022 | | |
| Pathogenicity | Anti-biofilm effects and characterisation of the hydrogen peroxide activity of a range of Western Australian honeys compared to Manuka and multifloral honeys. | Sindi A, Chawn MVB, Hernandez ME, Green K, Islam MK, Locher C, Hammer K. | Sci Rep | 10.1038/s41598-019-54217-8 | 2019 | |
| Evaluation of Acinetobacter baumannii, Klebsiella pneumoniae, and Staphylococcus aureus respiratory tract superinfections among patients with COVID-19 at a tertiary-care hospital in Tehran, Iran. | Mobarak-Qamsari M, Jenaghi B, Sahebi L, Norouzi-Shadehi M, Salehi MR, Shakoori-Farahani A, Khoshnevis H, Abdollahi A, Feizabadi MM. | Eur J Med Res | 10.1186/s40001-023-01303-3 | 2023 | | |
| Antimicrobial betalains. | Wijesinghe VN, Choo WS. | J Appl Microbiol | 10.1111/jam.15798 | 2022 | | |
| In Vitro Biological Activity of Natural Products from the Endophytic Fungus Paraboeremia selaginellae against Toxoplasma gondii. | Mazzone F, Simons VE, van Geelen L, Frank M, Mandi A, Kurtan T, Pfeffer K, Kalscheuer R. | Antibiotics (Basel) | 10.3390/antibiotics11091176 | 2022 | | |
| Pathogenicity | Identification of Anti-staphylococcal and Anti-biofilm Compounds by Repurposing the Medicines for Malaria Venture Pathogen Box. | Bhandari V, Chakraborty S, Brahma U, Sharma P. | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00365 | 2018 | |
| Pathogenicity | Novel pyrazoles as potent growth inhibitors of staphylococci, enterococci and Acinetobacter baumannii bacteria. | Alkhaibari I, Kc HR, Angappulige DH, Gilmore D, Alam MA. | Future Med Chem | 10.4155/fmc-2021-0140 | 2022 | |
| Pyrolized Diatomaceous Biomass Doped with Epitaxially Growing Hybrid Ag/TiO2 Nanoparticles: Synthesis, Characterisation and Antibacterial Application. | Brzozowska W, Wojtczak I, Railean V, Bekissanova Z, Trykowski G, Buszewski B, Sprynskyy M. | Materials (Basel) | 10.3390/ma16124345 | 2023 | | |
| Cladosins L-O, new hybrid polyketides from the endophytic fungus Cladosporium sphaerospermum WBS017. | Pan F, El-Kashef DH, Kalscheuer R, Muller WEG, Lee J, Feldbrugge M, Mandi A, Kurtan T, Liu Z, Wu W, Proksch P. | Eur J Med Chem | 10.1016/j.ejmech.2020.112159 | 2020 | | |
| Metabolism | Antimicrobial activities of Bacillus velezensis strains isolated from stingless bee products against methicillin-resistant Staphylococcus aureus. | Baharudin MMA, Ngalimat MS, Mohd Shariff F, Balia Yusof ZN, Karim M, Baharum SN, Sabri S. | PLoS One | 10.1371/journal.pone.0251514 | 2021 | |
| Crystal structure and Hirshfeld surface analysis of 3-(3-hy-droxy-phen-yl)-1-(1H-pyrrol-2-yl)prop-2-en-1-one hemihydrate. | Ismail AZ, Gunasekharan M, Karunakaran T, Mohd Faudzi SM. | Acta Crystallogr E Crystallogr Commun | 10.1107/s2056989023001925 | 2023 | | |
| Adaptive Laboratory Evolution of Staphylococcus aureus Resistance to Vancomycin and Daptomycin: Mutation Patterns and Cross-Resistance. | Gostev V, Kalinogorskaya O, Sopova J, Sulian O, Chulkova P, Velizhanina M, Tsvetkova I, Ageevets I, Ageevets V, Sidorenko S. | Antibiotics (Basel) | 10.3390/antibiotics12050928 | 2023 | | |
| Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India. | Bakthavatchalam YD, Babu P, Munusamy E, Dwarakanathan HT, Rupali P, Zervos M, John Victor P, Veeraraghavan B. | PLoS One | 10.1371/journal.pone.0227009 | 2019 | | |
| Four New Phloroglucinol-Terpene Adducts from the Leaves of Myrciaria cauliflora. | Chen M, Cao JQ, Wang WJ, Li NP, Wu Y, Wang L, Ye WC. | Nat Prod Bioprospect | 10.1007/s13659-020-00288-4 | 2021 | | |
| Real-time PCR assay for detection of Staphylococcus aureus, Panton-Valentine Leucocidin and Methicillin Resistance directly from clinical samples. | Galia L, Ligozzi M, Bertoncelli A, Mazzariol A. | AIMS Microbiol | 10.3934/microbiol.2019.2.138 | 2019 | | |
| Methicillin-Resistant Staphylococcus aureus from Peninsular Malaysian Animal Handlers: Molecular Profile, Antimicrobial Resistance, Immune Evasion Cluster and Genotypic Categorization. | Chai M, Sukiman MZ, Kamarun Baharin AH, Ramlan I, Lai LZ, Liew Y, Malayandy P, Mohamad NM, Choong S, Ariffin SMZ, Ghazali MF. | Antibiotics (Basel) | 10.3390/antibiotics11010103 | 2022 | | |
| New Copper Complexes with Antibacterial and Cytotoxic Activity. | Hangan AC, Lucaciu RL, Turza A, Dican L, Sevastre B, Pall E, Oprean LS, Borodi G. | Int J Mol Sci | 10.3390/ijms241813819 | 2023 | | |
| Enzymology | Hospitalization and colonization by methicillin-resistant Staphylococcus aureus in the surgical department of 03 health facilities in the Ndé division, West-Cameroon. | Nankam WLN, Kwetche PRF, Tazemda-Kuitsouc GB, Chouna GJD, Tekam JM. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-021-00451-w | 2021 | |
| Dehydroabietic Acid Microencapsulation Potential as Biofilm-Mediated Infections Treatment. | Neto I, Dominguez-Martin EM, Ntungwe E, Reis CP, Pesic M, Faustino C, Rijo P. | Pharmaceutics | 10.3390/pharmaceutics13060825 | 2021 | | |
| A new coumarin compound DCH combats methicillin-resistant Staphylococcus aureus biofilm by targeting arginine repressor. | Qu D, Hou Z, Li J, Luo L, Su S, Ye Z, Bai Y, Zhang X, Chen G, Li Z, Wang Y, Xue X, Luo X, Li M. | Sci Adv | 10.1126/sciadv.aay9597 | 2020 | | |
| Enhanced Bioactive Potential of Functionalized Injectable Platelet-Rich Plasma. | Pall E, Roman A, Olah D, Beteg FI, Cenariu M, Spinu M. | Molecules | 10.3390/molecules28041943 | 2023 | | |
| Enzymology | Au(III) Schiff base complexes as oxidoreductase inhibitors against carbapenem- and colistin-resistant Gram-negative bacteria via targeting redox active motifs. | Chen X, Lv L, Xu J, Shi J, Chen X, Zi G, Wu Y, Sun S, Pang Y, Song Q, Ma L, Wei S, Ma T, Liu W. | Redox Biol | 10.1016/j.redox.2025.103800 | 2025 | |
| Toxic Shock Syndrome Toxin 1-Producing Methicillin-Resistant Staphylococcus aureus of Clonal Complex 5, the New York/Japan Epidemic Clone, Causing a High Early-Mortality Rate in Patients with Bloodstream Infections. | Kim D, Hong JS, Yoon EJ, Lee H, Kim YA, Shin KS, Shin JH, Uh Y, Shin JH, Park YS, Jeong SH. | Antimicrob Agents Chemother | 10.1128/aac.01362-19 | 2019 | | |
| Rapid and Sensitive Detection of Antibiotic Resistance Genes by Utilizing TALEs as a Diagnostic Probe with 2D-Nanosheet Graphene Oxide. | Kang J, Nguyen VT, Kim MS. | Anal Chem | 10.1021/acs.analchem.3c00647 | 2023 | | |
| Phenotype | Phenotypic and Molecular Characterisation of Staphylococcus Aureus with Reduced Vancomycin Susceptibility Derivated in Vitro. | Xu J, Pang L, Ma XX, Hu J, Tian Y, Yang YL, Sun DD. | Open Med (Wars) | 10.1515/med-2018-0071 | 2018 | |
| Pathogenicity | Naphthoquinone-derivative as a synthetic compound to overcome the antibiotic resistance of methicillin-resistant S. aureus. | Song R, Yu B, Friedrich D, Li J, Shen H, Krautscheid H, Huang SD, Kim MH. | Commun Biol | 10.1038/s42003-020-01261-0 | 2020 | |
| An overview of the chemical composition and biological activities of essential oils from Alpinia genus (Zingiberaceae). | Van HT, Thang TD, Luu TN, Doan VD. | RSC Adv | 10.1039/d1ra07370b | 2021 | | |
| Pathogenicity | In vitro Antimicrobial Activity of Acne Drugs Against Skin-Associated Bacteria. | Blaskovich MAT, Elliott AG, Kavanagh AM, Ramu S, Cooper MA. | Sci Rep | 10.1038/s41598-019-50746-4 | 2019 | |
| Fungal Endophytes: A Potential Source of Antibacterial Compounds. | Deshmukh SK, Dufosse L, Chhipa H, Saxena S, Mahajan GB, Gupta MK. | J Fungi (Basel) | 10.3390/jof8020164 | 2022 | | |
| Pathogenicity | Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus. | Alnufaie R, Alsup N, Kc HR, Newman M, Whitt J, Chambers SA, Gilmore D, Alam MA. | J Antibiot (Tokyo) | 10.1038/s41429-020-0341-2 | 2020 | |
| Isolation and identification of enterotoxigenic Staphylococcus aureus isolates from Indian food samples: evaluation of in-house developed aptamer linked sandwich ELISA (ALISA) method. | Sundararaj N, Kalagatur NK, Mudili V, Krishna K, Antonysamy M. | J Food Sci Technol | 10.1007/s13197-019-03568-1 | 2019 | | |
| Cocktail of isobavachalcone and curcumin enhance eradication of Staphylococcus aureus biofilm from orthopedic implants by gentamicin and alleviate inflammatory osteolysis. | Chen Y, Hu H, Huang F, Ling Z, Chen B, Tan B, Wang T, Liu X, Liu C, Zou X. | Front Microbiol | 10.3389/fmicb.2022.958132 | 2022 | | |
| Pathogenicity | Antimicrobial and anti-biofilm activity of hexadentated macrocyclic complex of copper (II) derived from thiosemicarbazide against Staphylococcus aureus. | Brahma U, Kothari R, Sharma P, Bhandari V. | Sci Rep | 10.1038/s41598-018-26483-5 | 2018 | |
| Treated wastewater effluent increases pharmaceutical concentrations and alters benthic microbial communities in streams. | Lorentz B, Rauhauser M, Krantz RT, Snow DD, Kelly JJ. | Front Microbiol | 10.3389/fmicb.2025.1649739 | 2025 | | |
| HPLC-DAD phenolic screening and in vitro assessment of antimicrobial, antioxidant and anti-inflammatory activities of Tanteboucht dates. | Dassamiour S, Meguellati S, Lamraoui H, Bensaad MS, Sami R, Alshehry G, Althubaiti EH, Al-Meshal AS. | RSC Adv | 10.1039/d2ra01630c | 2022 | | |
| In vitro and in vivo evaluation of diethyldithiocarbamate with copper ions and its liposomal formulation for the treatment of Staphylococcus aureus and Staphylococcus epidermidis biofilms. | Kaul L, Abdo AI, Coenye T, Swift S, Zannettino A, Suss R, Richter K. | Biofilm | 10.1016/j.bioflm.2023.100130 | 2023 | | |
| QKI degradation in macrophage by RNF6 protects mice from MRSA infection via enhancing PI3K p110beta dependent autophagy. | Zhai D, Wang W, Ye Z, Xue K, Chen G, Hu S, Yan Z, Guo Y, Wang F, Li X, Xiang A, Li X, Lu Z, Wang L. | Cell Biosci | 10.1186/s13578-022-00865-9 | 2022 | | |
| Modified Fluoroquinolones as Antimicrobial Compounds Targeting Chlamydia trachomatis. | Vu TH, Adhel E, Vielfort K, Ha Duong NT, Anquetin G, Jeannot K, Verbeke P, Hjalmar S, Gylfe A, Serradji N. | Int J Mol Sci | 10.3390/ijms23126741 | 2022 | | |
| Detection, molecular characterization, and antibiogram of multi-drug resistant and methicillin-resistant Staphylococcus aureus (MRSA) isolated from pets and pet owners in Malaysia. | Chai MH, Sukiman MZ, Liew YW, Shapawi MS, Roslan FS, Hashim SN, Mohamad NM, Ariffin SMZ, Ghazali MF. | Iran J Vet Res | 10.22099/ijvr.2021.39586.5752 | 2021 | | |
| In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids. | Isca VMS, Andrade J, Fernandes AS, Paixao P, Uriel C, Gomez AM, Duarte N, Rijo P. | Molecules | 10.3390/molecules25184250 | 2020 | | |
| New Dual Inhibitors of Bacterial Topoisomerases with Broad-Spectrum Antibacterial Activity and In Vivo Efficacy against Vancomycin-Intermediate Staphylococcus aureus. | Durcik M, Cotman AE, Toplak Z, Mozina S, Skok Z, Szili PE, Czikkely M, Maharramov E, Vu TH, Piras MV, Zidar N, Ilas J, Zega A, Trontelj J, Pardo LA, Hughes D, Huseby D, Berruga-Fernandez T, Cao S, Simoff I, Svensson R, Korol SV, Jin Z, Vicente F, Ramos MC, Mundy JEA, Maxwell A, Stevenson CEM, Lawson DM, Glinghammar B, Sjostrom E, Bohlin M, Oreskar J, Alver S, Janssen GV, Sterk GJ, Kikelj D, Pal C, Tomasic T, Peterlin Masic L. | J Med Chem | 10.1021/acs.jmedchem.2c01905 | 2023 | | |
| Pathogenicity | The Pros and Cons of Cystic Fibrosis (CF) Patient Use of Herbal Supplements Containing Pulmonaria officinalis L. Extract: the Evidence from an In Vitro Study on Staphylococcus aureus CF Clinical Isolates. | Sadowska B, Wojcik U, Krzyzanowska-Kowalczyk J, Kowalczyk M, Stochmal A, Rywaniak J, Burzynska J, Rozalska B. | Molecules | 10.3390/molecules24061151 | 2019 | |
| Insights into the Biocompatibility and Biological Potential of a Chitosan Nanoencapsulated Textile Dye. | Costa EM, Silva S, Tavaria FK, Pintado M. | Int J Mol Sci | 10.3390/ijms232214234 | 2022 | | |
| SPS-neutralization in tissue samples for efficacy testing of antimicrobial peptides. | Dijksteel GS, Nibbering PH, Ulrich MMW, Middelkoop E, Boekema BKHL. | BMC Infect Dis | 10.1186/s12879-019-4700-1 | 2019 | | |
| Small Schiff Base Molecules-A Possible Strategy to Combat Biofilm-Related Infections. | Coanda M, Limban C, Nuta DC. | Antibiotics (Basel) | 10.3390/antibiotics13010075 | 2024 | | |
| Insights in the Antimicrobial Potential of the Natural Nisin Variant Nisin H. | Reiners J, Lagedroste M, Gottstein J, Adeniyi ET, Kalscheuer R, Poschmann G, Stuhler K, Smits SHJ, Schmitt L. | Front Microbiol | 10.3389/fmicb.2020.573614 | 2020 | | |
| Dual targeting of the class V lanthipeptide antibiotic cacaoidin. | Deisinger JP, Arts M, Kotsogianni I, Puls JS, Grein F, Ortiz-Lopez FJ, Martin NI, Muller A, Genilloud O, Schneider T. | iScience | 10.1016/j.isci.2023.106394 | 2023 | | |
| Phytochemical Profile, Antioxidant, Antimicrobial and Cytoprotective Effects of Cornelian Cherry (Cornus mas L.) Fruit Extracts. | Aurori M, Niculae M, Hanganu D, Pall E, Cenariu M, Vodnar DC, Bunea A, Fit N, Andrei S. | Pharmaceuticals (Basel) | 10.3390/ph16030420 | 2023 | | |
| N-(Hydroxyalkyl) Derivatives of tris(1H-indol-3-yl)methylium Salts as Promising Antibacterial Agents: Synthesis and Biological Evaluation. | Lavrenov SN, Isakova EB, Panov AA, Simonov AY, Tatarskiy VV, Trenin AS. | Pharmaceuticals (Basel) | 10.3390/ph13120469 | 2020 | | |
| In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus. | Narasimhaswamy N, Bairy I, Shenoy G, Bairy L. | Iran J Microbiol | 2017 | | ||
| Pathogenicity | 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents. | Hansa RK, Khan MMK, Frangie MM, Gilmore DF, Shelton RS, Savenka AV, Basnakian AG, Shuttleworth SL, Smeltzer MS, Alam MA. | Eur J Med Chem | 10.1016/j.ejmech.2021.113402 | 2021 | |
| Anti-Restriction Gene Homologs Are Highly Represented in Methicillin-Resistant and Multidrug-Resistant Staphylococcus aureus ST239 and ST398: Implications for Resistance Gene Acquisitions. | Silva DNS, Beltrame CO, Botelho AMN, Martini CL, Esteves MAC, Guedes IA, Dardenne LE, Figueiredo AMS. | Antibiotics (Basel) | 10.3390/antibiotics11091217 | 2022 | | |
| Pathogenicity | Antibacterial Activity of Ticagrelor in Conventional Antiplatelet Dosages Against Antibiotic-Resistant Gram-Positive Bacteria. | Lancellotti P, Musumeci L, Jacques N, Servais L, Goffin E, Pirotte B, Oury C. | JAMA Cardiol | 10.1001/jamacardio.2019.1189 | 2019 | |
| Pathogenicity | Antibacterial Activities and Synergistic Interaction of Citrus Essential Oils and Limonene with Gentamicin against Clinically Isolated Methicillin-Resistant Staphylococcus aureus. | Sreepian A, Popruk S, Nutalai D, Phutthanu C, Sreepian PM. | ScientificWorldJournal | 10.1155/2022/8418287 | 2022 | |
| Antibiotic Resistance and Molecular Profiling of the Clinical Isolates of Staphylococcus aureus Causing Bovine Mastitis from India. | Brahma U, Suresh A, Murthy S, Bhandari V, Sharma P. | Microorganisms | 10.3390/microorganisms10040833 | 2022 | | |
| Pathogenicity | Synthesis and Antimicrobial Studies of Coumarin-Substituted Pyrazole Derivatives as Potent Anti-Staphylococcus aureus Agents. | Alnufaie R, Raj Kc H, Alsup N, Whitt J, Andrew Chambers S, Gilmore D, Alam MA. | Molecules | 10.3390/molecules25122758 | 2020 | |
| Methicillin-Resistant Staphylococcus aureus (MRSA): Prevalence, Antimicrobial Susceptibility Pattern, and Detection of mecA Gene among Cardiac Patients from a Tertiary Care Heart Center in Kathmandu, Nepal. | Dhungel S, Rijal KR, Yadav B, Dhungel B, Adhikari N, Shrestha UT, Adhikari B, Banjara MR, Ghimire P. | Infect Dis (Auckl) | 10.1177/11786337211037355 | 2021 | | |
| Hop leaves: From waste to a valuable source of bioactive compounds - A multidisciplinary approach to investigating potential applications. | Sabbatini G, Mari E, Ortore MG, Di Gregorio A, Fattorini D, Di Carlo M, Galeazzi R, Vignaroli C, Simoni S, Giorgini G, Guarrasi V, Chiancone B, Leto L, Cirlini M, Del Vecchio L, Mangione MR, Vilasi S, Minnelli C, Mobbili G. | Heliyon | 10.1016/j.heliyon.2024.e37593 | 2024 | | |
| The combination of diethyldithiocarbamate and copper ions is active against Staphylococcus aureus and Staphylococcus epidermidis biofilms in vitro and in vivo. | Kaul L, Abdo AI, Coenye T, Krom BP, Hoogenkamp MA, Zannettino ACW, Suss R, Richter K. | Front Microbiol | 10.3389/fmicb.2022.999893 | 2022 | | |
| Amphiphilic azobenzene-neomycin conjugate self-assembles into nanostructures and transports plasmid DNA efficiently into the mammalian cells. | Yadav S, Deka SR, Jha D, Gautam HK, Sharma AK. | Colloids Surf B Biointerfaces | 10.1016/j.colsurfb.2016.09.008 | 2016 | | |
| Pathogenicity | The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-Resistant Staphylococcus aureus Bacteriolysis. | Indiani C, Sauve K, Raz A, Abdelhady W, Xiong YQ, Cassino C, Bayer AS, Schuch R. | Antimicrob Agents Chemother | 10.1128/aac.02291-18 | 2019 | |
| Pathogenicity | Synthesis of Chimeric Thiazolo-Nootkatone Derivatives as Potent Antimicrobial Agents. | Alkhaibari IS, Raj K C H, Alnufaie R, Gilmore D, Alam MA. | ChemMedChem | 10.1002/cmdc.202100230 | 2021 | |
| Cysteines and Disulfide-Bridged Macrocyclic Mimics of Teixobactin Analogues and Their Antibacterial Activity Evaluation against Methicillin-Resistant Staphylococcus Aureus (MRSA). | Malkawi R, Iyer A, Parmar A, Lloyd DG, Leng Goh ET, Taylor EJ, Sarmad S, Madder A, Lakshminarayanan R, Singh I. | Pharmaceutics | 10.3390/pharmaceutics10040183 | 2018 | | |
| Chemical Profile and Biological Effects of an Herbal Mixture for the Development of an Oil-in-Water Cream. | Safta DA, Ielciu I, Sustic R, Hanganu D, Niculae M, Cenariu M, Pall E, Moldovan ML, Achim M, Bogdan C, Tomuta I. | Plants (Basel) | 10.3390/plants12020248 | 2023 | | |
| Microwave assisted synthesis of negative-charge carbon dots with potential antibacterial activity against multi-drug resistant bacteria. | Kung JC, Tseng IT, Chien CS, Lin SH, Wang CC, Shih CJ. | RSC Adv | 10.1039/d0ra07106d | 2020 | | |
| Pathogenicity | Detection of heterogeneous vancomycin-intermediate Staphylococcus aureus: A preliminary report from south India. | Amberpet R, Sistla S, Sugumar M, Nagasundaram N, Manoharan M, Parija SC. | Indian J Med Res | 10.4103/ijmr.ijmr_1976_17 | 2019 | |
| Domino Reaction Protocol to Synthesize Benzothiophene-Derived Chemical Entities as Potential Therapeutic Agents. | Roy S, Budhathoki S, Iqbal AD, Erickson AN, Ali MA, Alam MA. | J Org Chem | 10.1021/acs.joc.3c02646 | 2024 | | |
| Hybrid Hydrogel Supplemented with Algal Polysaccharide for Potential Use in Biomedical Applications. | Stan D, Mirica AC, Mocanu S, Stan D, Podolean I, Candu N, El Fergani M, Stefan LM, Seciu-Grama AM, Aricov L, Brincoveanu O, Moldovan C, Bocancia-Mateescu LA, Coman SM. | Gels | 10.3390/gels11010017 | 2024 | | |
| Nasal Carriage by Staphylococcus aureus among Healthcare Workers and Students Attending a University Hospital in Southern Brazil: Prevalence, Phenotypic, and Molecular Characteristics. | Danelli T, Duarte FC, de Oliveira TA, da Silva RS, Frizon Alfieri D, Goncalves GB, de Oliveira CF, Tavares ER, Yamauchi LM, Perugini MRE, Yamada-Ogatta SF. | Interdiscip Perspect Infect Dis | 10.1155/2020/3808036 | 2020 | | |
| Pathogenicity | Strain-specific anti-biofilm and antibiotic-potentiating activity of 3',4'-difluoroquercetin. | Kho W, Kim MK, Jung M, Chong YP, Kim YS, Park KH, Chong Y. | Sci Rep | 10.1038/s41598-020-71025-7 | 2020 | |
| Pathogenicity | Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria. | Alkhaibari IS, Kc HR, Roy S, Abu-Gazleh MK, Gilmore DF, Alam MA. | Molecules | 10.3390/molecules26165083 | 2021 | |
| Pathogenicity | Selenium Nanoparticles as Candidates for Antibacterial Substitutes and Supplements against Multidrug-Resistant Bacteria. | Han HW, Patel KD, Kwak JH, Jun SK, Jang TS, Lee SH, Knowles JC, Kim HW, Lee HH, Lee JH. | Biomolecules | 10.3390/biom11071028 | 2021 | |
| Multilocus Sequence Typing Analysis of Invasive and Non-Invasive Group B Streptococcus of Hospital Origin in Malaysia. | Ezhumalai M, Muthanna A, Suhaili Z, Dzaraly ND, Amin-Nordin S, Amal MNA, Desa MNM. | Malays J Med Sci | 10.21315/mjms2020.27.1.14 | 2020 | | |
| Novel Cyclic Lipopeptides Fusaricidin Analogs for Treating Wound Infections. | Gil J, Pastar I, Houghten RA, Padhee S, Higa A, Solis M, Valdez J, Head CR, Michaels H, Lenhart B, Simms C, Williams B, Cudic P, Davis SC. | Front Microbiol | 10.3389/fmicb.2021.708904 | 2021 | | |
| Antibacterial potential of chalcones and its derivatives against Staphylococcus aureus. | da Silva L, Donato IA, Goncalves CAC, Scherf JR, Dos Santos HS, Mori E, Coutinho HDM, da Cunha FAB. | 3 Biotech | 10.1007/s13205-022-03398-7 | 2023 | | |
| Genetics | Last Decade Insights in Exploiting Marine Microorganisms as Sources of New Bioactive Natural Products. | Ragozzino C, Casella V, Coppola A, Scarpato S, Buonocore C, Consiglio A, Palma Esposito F, Galasso C, Tedesco P, Della Sala G, de Pascale D, Vitale L, Coppola D. | Mar Drugs | 10.3390/md23030116 | 2025 | |
| Phylogeny | Synthesis of biscoumarin and dihydropyran derivatives as two novel classes of potential anti-bacterial derivatives. | Li J, Xue XY, Li X, Hou Z, Yang XH, Qu D, Zhou Y, Zhang ZD, Luo XX, Li JT, Li MK. | Arch Pharm Res | 10.1007/s12272-015-0614-7 | 2016 | |
| Synthesis and Antimicrobial Studies of 4-[3-(3-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid and 4-[3-(4-Fluorophenyl)-4-formyl-1H-pyrazol-1-yl]benzoic Acid as Potent Growth Inhibitors of Drug-Resistant Bacteria. | Whitt J, Duke C, Ali MA, Chambers SA, Khan MMK, Gilmore D, Alam MA. | ACS Omega | 10.1021/acsomega.9b01967 | 2019 | | |
| The role of reactive oxygen species in the antimicrobial activity of pyochelin. | Ong KS, Cheow YL, Lee SM. | J Adv Res | 10.1016/j.jare.2017.05.007 | 2017 | | |
| Cryptic Metabolites from Marine-Derived Microorganisms Using OSMAC and Epigenetic Approaches. | Pinedo-Rivilla C, Aleu J, Duran-Patron R. | Mar Drugs | 10.3390/md20020084 | 2022 | | |
| Pathogenicity | New biscoumarin derivatives: synthesis, crystal structure, theoretical study and antibacterial activity against Staphylococcus aureus. | Qu D, Li J, Yang XH, Zhang ZD, Luo XX, Li MK, Li X. | Molecules | 10.3390/molecules191219868 | 2014 | |
| Pathogenicity | In vitro inhibitory and cytotoxic activity of MFM 501, a novel codonopsinine derivative, against Methicillin-Resistant Staphylococcus aureus clinical isolates. | Johari SA, Mohtar M, Mohammad SA, Sahdan R, Shaameri Z, Hamzah AS, Mohammat MF. | Biomed Res Int | 10.1155/2015/823829 | 2015 | |
| Pathogenicity | Antibiofilm Activity and Synergistic Inhibition of Staphylococcus aureus Biofilms by Bactericidal Protein P128 in Combination with Antibiotics. | Nair S, Desai S, Poonacha N, Vipra A, Sharma U. | Antimicrob Agents Chemother | 10.1128/aac.01118-16 | 2016 | |
| Decreased expression of femXAB genes and fnbp mediated biofilm pathways in OS-MRSA clinical isolates. | Brahma U, Sharma P, Murthy S, Sharma S, Chakraborty S, Appalaraju SN, Bhandari V. | Sci Rep | 10.1038/s41598-019-52557-z | 2019 | | |
| A Thermosensitive, Chitosan-Based Hydrogel as Delivery System for Antibacterial Liposomes to Surgical Site Infections. | Kaul L, Grundmann CE, Koll-Weber M, Loffler H, Weiz A, Zannettino ACW, Richter K, Suss R. | Pharmaceutics | 10.3390/pharmaceutics14122841 | 2022 | | |
| Synthesis, antibacterial activities, and theoretical studies of dicoumarols. | Li J, Hou Z, Chen GH, Li F, Zhou Y, Xue XY, Li ZP, Jia M, Zhang ZD, Li MK, Luo XX. | Org Biomol Chem | 10.1039/c4ob00772g | 2014 | | |
| Diversity of Multidrug Efflux Genes and Phenotypic Evaluation of the In vitro Resistance Dynamics of Clinical Staphylococcus Aureus Isolates Using Methicillin; a Model beta-lactam. | Antiabong JF, Kock MM, Bellea NM, Ehlers MM. | Open Microbiol J | 10.2174/1874285801711010132 | 2017 | | |
| Pathogenicity | Presentation of Antibacterial and Therapeutic Anti-inflammatory Potentials to Hydroxyapatite via Biomimetic With Azadirachta indica: An in vitro Anti-inflammatory Assessment in Contradiction of LPS-Induced Stress in RAW 264.7 Cells. | Nagaraj A, Samiappan S. | Front Microbiol | 10.3389/fmicb.2019.01757 | 2019 | |
| Methicillin-resistant Staphylococcus aureus carriage among medical students of Jimma University, Southwest Ethiopia. | Efa F, Alemu Y, Beyene G, Gudina EK, Kebede W. | Heliyon | 10.1016/j.heliyon.2019.e01191 | 2019 | | |
| Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines. | Suaifan GARY, Mohammed AAM, Alkhawaja BA. | Molecules | 10.3390/molecules27051658 | 2022 | | |
| Optimisation of preparation conditions for Ti nanowires and suitability as an antibacterial material. | Munisparan T, Yang ECY, Paramasivam R, Dahlan NA, Pushpamalar J. | IET Nanobiotechnol | 10.1049/iet-nbt.2017.0186 | 2018 | | |
| Pathogenicity | Synthesis, crystal structures, and anti-drug-resistant Staphylococcus aureus activities of novel 4-hydroxycoumarin derivatives. | Li MK, Li J, Liu BH, Zhou Y, Li X, Xue XY, Hou Z, Luo XX. | Eur J Pharmacol | 10.1016/j.ejphar.2013.09.040 | 2013 | |
| Detection of heterogeneous vancomycin intermediate resistance in MRSA isolates from Latin America. | Castro BE, Berrio M, Vargas ML, Carvajal LP, Millan LV, Rios R, Hernandez AK, Rincon S, Cubides P, Forero E, Dinh A, Seas C, Munita JM, Arias CA, Reyes J, Diaz L. | J Antimicrob Chemother | 10.1093/jac/dkaa221 | 2020 | | |
| Enzymology | Gold(I) selenium N-heterocyclic carbene complexes as potent antibacterial agents against multidrug-resistant gram-negative bacteria via inhibiting thioredoxin reductase. | Chen X, Sun S, Huang S, Yang H, Ye Q, Lv L, Liang Y, Shan J, Xu J, Liu W, Ma T. | Redox Biol | 10.1016/j.redox.2023.102621 | 2023 | |
| Heteroaryl-Ethylenes as New Lead Compounds in the Fight against High Priority Bacterial Strains. | Bongiorno D, Musso N, Bonacci PG, Bivona DA, Massimino M, Stracquadanio S, Bonaccorso C, Fortuna CG, Stefani S. | Antibiotics (Basel) | 10.3390/antibiotics10091034 | 2021 | | |
| Multi Locus Sequence Typing and spa Typing of Staphylococcus Aureus Isolated from the Milk of Cows with Subclinical Mastitis in Croatia. | Cvetnic L, Samardzija M, Duvnjak S, Habrun B, Cvetnic M, Jaki Tkalec V, Duricic D, Benic M. | Microorganisms | 10.3390/microorganisms9040725 | 2021 | | |
| Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus? | Bakthavatchalam YD, Ralph R, Veeraraghavan B, Babu P, Munusamy E. | Infect Dis Ther | 10.1007/s40121-018-0224-z | 2019 | | |
| Metabolism | Host cell invasion by Staphylococcus aureus stimulates the shedding of microvesicles. | DeWalt RI, Petkovich DA, Zahrt AN, Bruns HA, McDowell SA. | Biochem Biophys Res Commun | 10.1016/j.bbrc.2013.01.122 | 2013 | |
| A structural study of TatD from Staphylococcus aureus elucidates a putative DNA-binding mode of a Mg2+-dependent nuclease. | Lee KY, Cheon SH, Kim DG, Lee SJ, Lee BJ. | IUCrJ | 10.1107/s2052252520003917 | 2020 | | |
| Metabolism | Docking studies and molecular dynamics simulations of the binding characteristics of waldiomycin and its methyl ester analog to Staphylococcus aureus histidine kinase. | Radwan A, Mahrous GM. | PLoS One | 10.1371/journal.pone.0234215 | 2020 | |
| Draft Genome Sequence of Paenibacillus sp. Strain MSt1 with Broad Antimicrobial Activity, Isolated from Malaysian Tropical Peat Swamp Soil. | Aw YK, Ong KS, Yule CM, Gan HM, Lee SM. | Genome Announc | 10.1128/genomea.01024-14 | 2014 | | |
| Antiproliferative and Antimicrobial Effects of Rosmarinus officinalis L. Loaded Liposomes. | Ielciu I, Niculae M, Pall E, Barbalata C, Tomuta I, Olah NK, Burtescu RF, Benedec D, Oniga I, Hanganu D. | Molecules | 10.3390/molecules27133988 | 2022 | | |
| Enzymology | Characteristics of glycopeptide-resistant Staphylococcus aureus strains isolated from inpatients of three teaching hospitals in Warsaw, Poland. | Szymanek-Majchrzak K, Mlynarczyk A, Mlynarczyk G. | Antimicrob Resist Infect Control | 10.1186/s13756-018-0397-y | 2018 | |
| Draft Genome Sequences of Two Antimicrobial-Producing Burkholderia sp. Strains, MSh1 and MSh2, Isolated from Malaysian Tropical Peat Swamp Forest Soil. | Ong KS, Aw YK, Gan HM, Yule CM, Lee SM. | Genome Announc | 10.1128/genomea.01032-14 | 2014 | | |
| Pathogenicity | Marine sponge alkaloids as a source of anti-bacterial adjuvants. | Melander RJ, Liu HB, Stephens MD, Bewley CA, Melander C. | Bioorg Med Chem Lett | 10.1016/j.bmcl.2016.11.018 | 2016 | |
| Detection of Methicillin Resistant Staphylococcus aureus and Determination of Minimum Inhibitory Concentration of Vancomycin for Staphylococcus aureus Isolated from Pus/Wound Swab Samples of the Patients Attending a Tertiary Care Hospital in Kathmandu, Nepal. | Adhikari R, Pant ND, Neupane S, Neupane M, Bhattarai R, Bhatta S, Chaudhary R, Lekhak B. | Can J Infect Dis Med Microbiol | 10.1155/2017/2191532 | 2017 | | |
| Metabolism | Effect of vancomycin on the cytoplasmic membrane fatty acid profile of vancomycin-resistant and -susceptible isolates of Staphylococcus aureus. | Mirani ZA, Jamil N. | J Infect Chemother | 10.1007/s10156-012-0447-y | 2013 | |
| Synthesis of Biscoumarin and Dihydropyran Derivatives and Evaluation of Their Antibacterial Activity. | Li J, Lv CW, Li XJ, Qu D, Hou Z, Jia M, Luo XX, Li X, Li MK. | Molecules | 10.3390/molecules200917469 | 2015 | | |
| Discovery of N-quinazolinone-4-hydroxy-2-quinolone-3-carboxamides as DNA gyrase B-targeted antibacterial agents. | Xue W, Wang Y, Lian X, Li X, Pang J, Kirchmair J, Wu K, Han Z, You X, Zhang H, Xia J, Wu S. | J Enzyme Inhib Med Chem | 10.1080/14756366.2022.2084088 | 2022 | | |
| Pathogenicity | Identification of 5,6-dihydroimidazo[2,1-b]thiazoles as a new class of antimicrobial agents. | Li Y, Bionda N, Fleeman R, Wang H, Ozawa A, Houghten RA, Shaw L. | Bioorg Med Chem | 10.1016/j.bmc.2016.09.027 | 2016 | |
| Novel Chalcone-Thiazole Hybrids as Potent Inhibitors of Drug Resistant Staphylococcus aureus. | Sashidhara KV, Rao KB, Kushwaha P, Modukuri RK, Singh P, Soni I, Shukla PK, Chopra S, Pasupuleti M. | ACS Med Chem Lett | 10.1021/acsmedchemlett.5b00169 | 2015 | | |
| Lipoplexes to Deliver Oligonucleotides in Gram-Positive and Gram-Negative Bacteria: Towards Treatment of Blood Infections. | Pereira S, Santos RS, Moreira L, Guimaraes N, Gomes M, Zhang H, Remaut K, Braeckmans K, De Smedt S, Azevedo NF. | Pharmaceutics | 10.3390/pharmaceutics13070989 | 2021 | | |
| The role of the msaABCR operon in implant-associated chronic osteomyelitis in Staphylococcus aureus USA300 LAC. | Sahukhal GS, Tucci M, Benghuzzi H, Wilson G, Elasri MO. | BMC Microbiol | 10.1186/s12866-020-01964-8 | 2020 | | |
| Characterization of Tn5801.Sag, a variant of Staphylococcus aureus Tn916 family transposon Tn5801 that is widespread in clinical isolates of Streptococcus agalactiae. | Mingoia M, Morici E, Tili E, Giovanetti E, Montanari MP, Varaldo PE. | Antimicrob Agents Chemother | 10.1128/aac.00521-13 | 2013 | | |
| Innovative Strategies Toward the Disassembly of the EPS Matrix in Bacterial Biofilms. | Pinto RM, Soares FA, Reis S, Nunes C, Van Dijck P. | Front Microbiol | 10.3389/fmicb.2020.00952 | 2020 | | |
| Pathogenicity | Synthesis of New Fluoro-Benzimidazole Derivatives as an Approach towards the Discovery of Novel Intestinal Antiseptic Drug Candidates. | Cevik UA, Saglik BN, Ozkay Y, Canturk Z, Bueno J, Demirci F, Koparal AS. | Curr Pharm Des | 10.2174/1381612822666161201150131 | 2017 | |
| Pathogenicity | Natural brominated phenoxyphenols kill persistent and biofilm-incorporated cells of MRSA and other pathogenic bacteria. | van Geelen L, Kaschani F, Sazzadeh SS, Adeniyi ET, Meier D, Proksch P, Pfeffer K, Kaiser M, Ioerger TR, Kalscheuer R. | Appl Microbiol Biotechnol | 10.1007/s00253-020-10654-4 | 2020 | |
| FtsZ filament structures in different nucleotide states reveal the mechanism of assembly dynamics. | Ruiz FM, Huecas S, Santos-Aledo A, Prim EA, Andreu JM, Fernandez-Tornero C. | PLoS Biol | 10.1371/journal.pbio.3001497 | 2022 | | |
| Pathogenicity | Evolution and Antibacterial Evaluation of 8-Hydroxy-cycloberberine Derivatives as a Novel Family of Antibacterial Agents Against MRSA. | Yang YS, Wei W, Hu XX, Tang S, Pang J, You XF, Fan TY, Wang YX, Song DQ. | Molecules | 10.3390/molecules24050984 | 2019 | |
| Teixobactin analogues reveal enduracididine to be non-essential for highly potent antibacterial activity and lipid II binding. | Parmar A, Iyer A, Prior SH, Lloyd DG, Leng Goh ET, Vincent CS, Palmai-Pallag T, Bachrati CZ, Breukink E, Madder A, Lakshminarayanan R, Taylor EJ, Singh I. | Chem Sci | 10.1039/c7sc03241b | 2017 | | |
| Extraction and Identification of Antibacterial Secondary Metabolites from Marine Streptomyces sp. VITBRK2. | Rajan BM, Kannabiran K. | Int J Mol Cell Med | 2014 | | ||
| Pathogenicity | Oritavancin disrupts membrane integrity of Staphylococcus aureus and vancomycin-resistant enterococci to effect rapid bacterial killing. | Belley A, McKay GA, Arhin FF, Sarmiento I, Beaulieu S, Fadhil I, Parr TR, Moeck G. | Antimicrob Agents Chemother | 10.1128/aac.00760-10 | 2010 | |
| Enzymology | Linezolid pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. | Strukova EN, Smirnova MV, Vostrov SN, Lubenko IY, Firsov AA, Zinner SH, Portnoy YA. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2008.09.006 | 2009 | |
| Multistep virtual screening for rapid and efficient identification of non-nucleoside bacterial thymidine kinase inhibitors. | Zander J, Hartenfeller M, Hahnke V, Proschak E, Besier S, Wichelhaus TA, Schneider G. | Chemistry | 10.1002/chem.201001347 | 2010 | | |
| Catalytic asymmetric total syntheses of myrtucommuacetalone, myrtucommuacetalone B, and callistrilones A, C, D and E. | Cheng MJ, Cao JQ, Yang XY, Zhong LP, Hu LJ, Lu X, Hou BL, Hu YJ, Wang Y, You XF, Wang L, Ye WC, Li CC. | Chem Sci | 10.1039/c7sc04672c | 2018 | | |
| Enzymology | Cellular Pharmacokinetics and Intracellular Activity of Gepotidacin against Staphylococcus aureus Isolates with Different Resistance Phenotypes in Models of Cultured Phagocytic Cells. | Peyrusson F, Tulkens PM, Van Bambeke F. | Antimicrob Agents Chemother | 10.1128/aac.02245-17 | 2018 | |
| Pathogenicity | Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections. | Faghih O, Zhang Z, Ranade RM, Gillespie JR, Creason SA, Huang W, Shibata S, Barros-Alvarez X, Verlinde CLMJ, Hol WGJ, Fan E, Buckner FS. | Antimicrob Agents Chemother | 10.1128/aac.00999-17 | 2017 | |
| Pathogenicity | Synthesis and Antibacterial Activity of Quaternary Ammonium 4-Deoxypyridoxine Derivatives. | Shtyrlin NV, Sapozhnikov SV, Galiullina AS, Kayumov AR, Bondar OV, Mirchink EP, Isakova EB, Firsov AA, Balakin KV, Shtyrlin YG. | Biomed Res Int | 10.1155/2016/3864193 | 2016 | |
| Methicillin Resistant Staphylococcus aureus Carriage, Antibiotic Resistance and Molecular Pathogenicity among Healthy Individuals Exposed and Not Exposed to Hospital Environment. | Krishnamurthy V, Saha A, Renushri BV, Nagaraj ER. | J Clin Diagn Res | 10.7860/jcdr/2014/8409.4638 | 2014 | | |
| Antibacterial and Antitumor Activities of Biscoumarin and Dihydropyran Derivatives. | Sui YP, Huo HR, Xin JJ, Li J, Li XJ, Du XL, Ma H, Zhou HY, Zhan HD, Wang ZJ, Li C, Sui F, Li MK. | Molecules | 10.3390/molecules200917614 | 2015 | | |
| Antibacterial Activity and Mechanism of Action of Aspidinol Against Multi-Drug-Resistant Methicillin-Resistant Staphylococcus aureus. | Hua X, Yang Q, Zhang W, Dong Z, Yu S, Schwarz S, Liu S. | Front Pharmacol | 10.3389/fphar.2018.00619 | 2018 | | |
| Metabolism | The potential of bacteriophage cocktail in eliminating Methicillin-resistant Staphylococcus aureus biofilms in terms of different extracellular matrices expressed by PIA, ciaA-D and FnBPA genes. | Abdulamir AS, Jassim SA, Hafidh RR, Bakar FA. | Ann Clin Microbiol Antimicrob | 10.1186/s12941-015-0106-0 | 2015 | |
| Unravelling the synthetic and therapeutic aspects of five, six and fused heterocycles using Vilsmeier-Haack reagent. | Chahal M, Dhillon S, Rani P, Kumari G, Aneja DK, Kinger M. | RSC Adv | 10.1039/d3ra04309f | 2023 | | |
| Pathogenicity | Enterotoxin gene profiles among Staphylococcus aureus isolated from raw milk. | Nazari R, Godarzi H, Rahimi Baghi F, Moeinrad M. | Iran J Vet Res | 2014 | | |
| Genetics | Relationship between super antigenicity, antimicrobial resistance and origin of Staphylococcus aureus isolated. | Corredor Arias LF, Luligo Espinal JS, Moncayo Ortiz JI, Santacruz Ibarra JJ, Alvarez Aldana A. | Colomb Med (Cali) | 10.25100/cm.v47i1.1818 | 2016 | |
| Clinical Significance of Manuka and Medical-Grade Honey for Antibiotic-Resistant Infections: A Systematic Review. | Nolan VC, Harrison J, Wright JEE, Cox JAG. | Antibiotics (Basel) | 10.3390/antibiotics9110766 | 2020 | | |
| Secondary metabolites in topical infectious diseases and nanomedicine applications. | Sahoo A, Dwivedi K, Almalki WH, Mandal AK, Alhamyani A, Afzal O, Alfawaz Altamimi AS, Alruwaili NK, Yadav PK, Barkat MA, Singh T, Rahman M. | Nanomedicine (Lond) | 10.2217/nnm-2024-0017 | 2024 | | |
| An FDA-Drug Library Screen for Compounds with Bioactivities against Meticillin-Resistant Staphylococcus aureus (MRSA). | Lau QY, Tan YY, Goh VC, Lee DJ, Ng FM, Ong EH, Hill J, Chia CS. | Antibiotics (Basel) | 10.3390/antibiotics4040424 | 2015 | | |
| Formulation and Comprehensive Evaluation of Biohybrid Hydrogel Membranes Containing Doxycycline or Silver Nanoparticles. | Stan D, Ruta LL, Bocancia-Mateescu LA, Mirica AC, Stan D, Micutz M, Brincoveanu O, Enciu AM, Codrici E, Popescu ID, Popa ML, Rotaru F, Tanase C. | Pharmaceutics | 10.3390/pharmaceutics15122696 | 2023 | | |
| The Antimicrobial Properties of Cannabis and Cannabis-Derived Compounds and Relevance to CB2-Targeted Neurodegenerative Therapeutics. | Hong H, Sloan L, Saxena D, Scott DA. | Biomedicines | 10.3390/biomedicines10081959 | 2022 | | |
| Effects of a New Emollient-Based Treatment on Skin Microflora Balance and Barrier Function in Children with Mild Atopic Dermatitis. | Bianchi P, Theunis J, Casas C, Villeneuve C, Patrizi A, Phulpin C, Bacquey A, Redoules D, Mengeaud V, Schmitt AM. | Pediatr Dermatol | 10.1111/pde.12786 | 2016 | | |
| Pathogenicity | Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India. | Mittal G, Bhandari V, Gaind R, Rani V, Chopra S, Dawar R, Sardana R, Verma PK. | BMC Infect Dis | 10.1186/s12879-019-4368-6 | 2019 | |
| Crystal Structure of an Invasivity-Associated Domain of SdrE in S. aureus. | Luo M, Zhang X, Zhang S, Zhang H, Yang W, Zhu Z, Chen K, Bai L, Wei J, Huang A, Wang D. | PLoS One | 10.1371/journal.pone.0168814 | 2017 | | |
| Enzymology | Longitudinal study of Staphylococcus aureus colonization and infection in a cohort of swine veterinarians in the United States. | Sun J, Yang M, Sreevatsan S, Bender JB, Singer RS, Knutson TP, Marthaler DG, Davies PR. | BMC Infect Dis | 10.1186/s12879-017-2802-1 | 2017 | |
| Hyaluronic acid association with bacterial, fungal and viral infections: Can hyaluronic acid be used as an antimicrobial polymer for biomedical and pharmaceutical applications? | Zamboni F, Wong CK, Collins MN. | Bioact Mater | 10.1016/j.bioactmat.2022.04.023 | 2023 | | |
| Metabolism | Staphylococcus aureus produces membrane-derived vesicles that induce host cell death. | Gurung M, Moon DC, Choi CW, Lee JH, Bae YC, Kim J, Lee YC, Seol SY, Cho DT, Kim SI, Lee JC. | PLoS One | 10.1371/journal.pone.0027958 | 2011 | |
| Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus. | Sirichoat A, Wongthong S, Kanyota R, Tavichakorntrakool R, Chanawong A, Welbat JU, Lulitanond A. | Jundishapur J Microbiol | 10.5812/jjm.26069 | 2016 | | |
| Pathogenicity | Structure, Function, and Inhibition of Staphylococcus aureus Heptaprenyl Diphosphate Synthase. | Desai J, Liu YL, Wei H, Liu W, Ko TP, Guo RT, Oldfield E. | ChemMedChem | 10.1002/cmdc.201600311 | 2016 | |
| Pathogenicity | Antimicrobial activities of twenty lysine-peptoid hybrids against clinically relevant bacteria and fungi. | Ryge TS, Frimodt-Moller N, Hansen PR. | Chemotherapy | 10.1159/000119707 | 2008 | |
| Prevalence of Enterotoxigenic Staphylococcus aureus Isolated From Chicken Nugget in Iran. | Madahi H, Rostami F, Rahimi E, Safarpoor Dehkordi F. | Jundishapur J Microbiol | 10.5812/jjm.10237 | 2014 | | |
| Pathogenicity | MRSA from Santa Catarina State, Southern Brazil: intriguing epidemiological differences compared to other Brazilian regions. | Silveira AC, Cunha GR, Caierao J, Cordova CM, d'Azevedo PA. | Braz J Infect Dis | 10.1016/j.bjid.2015.04.009 | 2015 | |
| Expression, purification, crystallization and preliminary X-ray analysis of the receiver domain of Staphylococcus aureus LytR protein. | Shala A, Patel KH, Golemi-Kotra D, Audette GF. | Acta Crystallogr Sect F Struct Biol Cryst Commun | 10.1107/s1744309113030972 | 2013 | | |
| Discovery and Development of 8-Substituted Cycloberberine Derivatives as Novel Antibacterial Agents against MRSA. | Fan T, Hu X, Tang S, Liu X, Wang Y, Deng H, You X, Jiang J, Li Y, Song D. | ACS Med Chem Lett | 10.1021/acsmedchemlett.8b00094 | 2018 | | |
| Pathogenicity | The MUT056399 inhibitor of FabI is a new antistaphylococcal compound. | Escaich S, Prouvensier L, Saccomani M, Durant L, Oxoby M, Gerusz V, Moreau F, Vongsouthi V, Maher K, Morrissey I, Soulama-Mouze C. | Antimicrob Agents Chemother | 10.1128/aac.01248-10 | 2011 | |
| Phylogeny | Detection of methicillin-resistant Staphylococcus aureus by a duplex droplet digital PCR assay. | Kelley K, Cosman A, Belgrader P, Chapman B, Sullivan DC. | J Clin Microbiol | 10.1128/jcm.00196-13 | 2013 | |
| Identification of GXXXXG motif in Chrysophsin-1 and its implication in the design of analogs with cell-selective antimicrobial and anti-endotoxin activities. | Tripathi AK, Kumari T, Harioudh MK, Yadav PK, Kathuria M, Shukla PK, Mitra K, Ghosh JK. | Sci Rep | 10.1038/s41598-017-03576-1 | 2017 | | |
| Antimicrobial activity and mechanism of action of Nu-3, a protonated modified nucleotide. | Cao S, Sun LQ, Wang M. | Ann Clin Microbiol Antimicrob | 10.1186/1476-0711-10-1 | 2011 | | |
| Enzymology | Enterotoxigenicity of Staphylococcus aureus isolated from traditional and commercial dairy products marketed in Iran. | Rahimi E. | Braz J Microbiol | 10.1590/s1517-83822013000200008 | 2013 | |
| Pathogenicity | 3-O-Methyl-Alkylgallates Inhibit Fatty Acid Desaturation in Mycobacterium tuberculosis. | Rehberg N, Omeje E, Ebada SS, van Geelen L, Liu Z, Sureechatchayan P, Kassack MU, Ioerger TR, Proksch P, Kalscheuer R. | Antimicrob Agents Chemother | 10.1128/aac.00136-19 | 2019 | |
| Pathogenicity | Disruption of allosteric response as an unprecedented mechanism of resistance to antibiotics. | Fishovitz J, Rojas-Altuve A, Otero LH, Dawley M, Carrasco-Lopez C, Chang M, Hermoso JA, Mobashery S. | J Am Chem Soc | 10.1021/ja5030657 | 2014 | |
| Metabolism | Structural and functional studies of SAV0551 from Staphylococcus aureus as a chaperone and glyoxalase III. | Kim HJ, Lee KY, Kwon AR, Lee BJ. | Biosci Rep | 10.1042/bsr20171106 | 2017 | |
| Pathogenicity | Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus. | Cheng J, Thanassi JA, Thoma CL, Bradbury BJ, Deshpande M, Pucci MJ. | Antimicrob Agents Chemother | 10.1128/aac.00158-07 | 2007 | |
| Pathogenicity | Vancomycin and daptomycin minimum inhibitory concentration distribution and occurrence of heteroresistance among methicillin-resistant Staphylococcus aureus blood isolates in Turkey. | Sancak B, Yagci S, Gur D, Gulay Z, Ogunc D, Soyletir G, Yalcin AN, Dundar DO, Topcu AW, Aksit F, Usluer G, Ozakin C, Akalin H, Hayran M, Korten V. | BMC Infect Dis | 10.1186/1471-2334-13-583 | 2013 | |
| Pathogenicity | Evaluation of a new Etest vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA. | Yusof A, Engelhardt A, Karlsson A, Bylund L, Vidh P, Mills K, Wootton M, Walsh TR. | J Clin Microbiol | 10.1128/jcm.00265-08 | 2008 | |
| Pathogenicity | Evaluation of vancomycin in combination with piperacillin-tazobactam or oxacillin against clinical methicillin-resistant Staphylococcus aureus Isolates and vancomycin-intermediate S. aureus isolates in vitro. | Dilworth TJ, Sliwinski J, Ryan K, Dodd M, Mercier RC. | Antimicrob Agents Chemother | 10.1128/aac.01888-13 | 2014 | |
| Pathogenicity | In vitro and in vivo antibacterial activities of heteroaryl isothiazolones against resistant gram-positive pathogens. | Pucci MJ, Cheng J, Podos SD, Thoma CL, Thanassi JA, Buechter DD, Mushtaq G, Vigliotti GA, Bradbury BJ, Deshpande M. | Antimicrob Agents Chemother | 10.1128/aac.01315-06 | 2007 | |
| Pathogenicity | Staphylococcal Enterotoxins Dose-Dependently Modulate the Generation of Myeloid-Derived Suppressor Cells. | Stoll H, Ost M, Singh A, Mehling R, Neri D, Schafer I, Velic A, Macek B, Kretschmer D, Weidenmaier C, Hector A, Handgretinger R, Gotz F, Peschel A, Hartl D, Rieber N. | Front Cell Infect Microbiol | 10.3389/fcimb.2018.00321 | 2018 | |
| Pathogenicity | Genetic background and antibiotic resistance of Staphylococcus aureus strains isolated in the Republic of Georgia. | Revazishvili T, Bakanidze L, Gomelauri T, Zhgenti E, Chanturia G, Kekelidze M, Rajanna C, Kreger A, Sulakvelidze A. | J Clin Microbiol | 10.1128/jcm.01030-06 | 2006 | |
| Pathogenicity | Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR. | Kato Y, Suzuki T, Ida T, Maebashi K. | J Antimicrob Chemother | 10.1093/jac/dkp394 | 2010 | |
| Antioxidant activity and antibacterial evaluation of new thiazolin-4-one derivatives as potential tryptophanyl-tRNA synthetase inhibitors. | Stana A, Vodnar DC, Marc G, Benedec D, Tiperciuc B, Tamaian R, Oniga O. | J Enzyme Inhib Med Chem | 10.1080/14756366.2019.1596086 | 2019 | | |
| Pathogenicity | A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically. | Koeth LM, DiFranco-Fisher JM, McCurdy S. | J Vis Exp | 10.3791/53028 | 2015 | |
| Benzofuranyl Esters: Synthesis, Crystal Structure Determination, Antimicrobial and Antioxidant Activities. | Kumar CS, Then LY, Chia TS, Chandraju S, Win YF, Sulaiman SF, Hashim NS, Ooi KL, Quah CK, Fun HK. | Molecules | 10.3390/molecules200916566 | 2015 | | |
| Metabolism | Chitosan-Lysozyme Conjugates for Enzyme-Triggered Hydrogel Degradation in Tissue Engineering Applications. | Kim S, Cui ZK, Koo B, Zheng J, Aghaloo T, Lee M. | ACS Appl Mater Interfaces | 10.1021/acsami.8b15591 | 2018 | |
| Pathogenicity | Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998. | Kelley WL, Jousselin A, Barras C, Lelong E, Renzoni A. | Antimicrob Agents Chemother | 10.1128/aac.04068-14 | 2015 | |
| Antimicrobial activity of Hemidesmus indicus, Ficus bengalensis and Pterocarpus marsupium roxb. | Gayathri M, Kannabiran K. | Indian J Pharm Sci | 10.4103/0250-474x.58182 | 2009 | | |
| Pathogenicity | Discovery and characterization of potent thiazoles versus methicillin- and vancomycin-resistant Staphylococcus aureus. | Mohammad H, Mayhoub AS, Ghafoor A, Soofi M, Alajlouni RA, Cushman M, Seleem MN. | J Med Chem | 10.1021/jm401905m | 2014 | |
| Prevalence of chlorhexidine-resistant methicillin-resistant Staphylococcus aureus following prolonged exposure. | Schlett CD, Millar EV, Crawford KB, Cui T, Lanier JB, Tribble DR, Ellis MW. | Antimicrob Agents Chemother | 10.1128/aac.02419-14 | 2014 | | |
| Effect of ester to amide or N-methylamide substitution on bacterial membrane depolarization and antibacterial activity of novel cyclic lipopeptides. | Bionda N, Fleeman RM, Shaw LN, Cudic P. | ChemMedChem | 10.1002/cmdc.201300173 | 2013 | | |
| Pathogenicity | Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening. | Cazares-Dominguez V, Cruz-Cordova A, Ochoa SA, Escalona G, Arellano-Galindo J, Rodriguez-Leviz A, Hernandez-Castro R, Lopez-Villegas EO, Xicohtencatl-Cortes J. | PLoS One | 10.1371/journal.pone.0118791 | 2015 | |
| Metabolism | A New Natural Product Analog of Blasticidin S Reveals Cellular Uptake Facilitated by the NorA Multidrug Transporter. | Davison JR, Lohith KM, Wang X, Bobyk K, Mandadapu SR, Lee SL, Cencic R, Nelson J, Simpkins S, Frank KM, Pelletier J, Myers CL, Piotrowski J, Smith HE, Bewley CA. | Antimicrob Agents Chemother | 10.1128/aac.02635-16 | 2017 | |
| Piscidin-1-analogs with double L- and D-lysine residues exhibited different conformations in lipopolysaccharide but comparable anti-endotoxin activities. | Kumar A, Kumar A, Mahajan M, Awasthi B, Tandon A, Harioudh MK, Shree S, Singh P, Shukla PK, Ramachandran R, Mitra K, Bhattacharjya S, Ghosh JK. | Sci Rep | 10.1038/srep39925 | 2017 | | |
| Pathogenicity | Mechanistic assessment of DNA ligase as an antibacterial target in Staphylococcus aureus. | Podos SD, Thanassi JA, Pucci MJ. | Antimicrob Agents Chemother | 10.1128/aac.00215-12 | 2012 | |
| Pathogenicity | In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus. | Lu X, Yang X, Li X, Lu Y, Ren Z, Zhao L, Hu X, Jiang J, You X. | PLoS One | 10.1371/journal.pone.0068053 | 2013 | |
| Dicoumarol: from chemistry to antitumor benefits. | Silva VLM, Silva-Reis R, Moreira-Pais A, Ferreira T, Oliveira PA, Ferreira R, Cardoso SM, Sharifi-Rad J, Butnariu M, Costea MA, Grozea I. | Chin Med | 10.1186/s13020-022-00699-0 | 2022 | | |
| Potential cannabidiol (CBD) repurposing as antibacterial and promising therapy of CBD plus polymyxin B (PB) against PB-resistant gram-negative bacilli. | Abichabki N, Zacharias LV, Moreira NC, Bellissimo-Rodrigues F, Moreira FL, Benzi JRL, Ogasawara TMC, Ferreira JC, Ribeiro CM, Pavan FR, Pereira LRL, Brancini GTP, Braga GUL, Zuardi AW, Hallak JEC, Crippa JAS, Lanchote VL, Canton R, Darini ALC, Andrade LN. | Sci Rep | 10.1038/s41598-022-10393-8 | 2022 | | |
| Pathogenicity | Incidence and characteristics of vancomycin nonsusceptible strains of methicillin-resistant Staphylococcus aureus at Hershey Medical Center. | Kosowska-Shick K, Ednie LM, McGhee P, Smith K, Todd CD, Wehler A, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.01073-08 | 2008 | |
| Pathogenicity | Antimicrobial Activity and Cell Selectivity of Synthetic and Biosynthetic Cationic Polymers. | Venkatesh M, Barathi VA, Goh ETL, Anggara R, Fazil MHUT, Ng AJY, Harini S, Aung TT, Fox SJ, Liu S, Yang L, Barkham TMS, Loh XJ, Verma NK, Beuerman RW, Lakshminarayanan R. | Antimicrob Agents Chemother | 10.1128/aac.00469-17 | 2017 | |
| Metabolism | Comparative Prevalence of Immune Evasion Complex Genes Associated with beta-Hemolysin Converting Bacteriophages in MRSA ST5 Isolates from Swine, Swine Facilities, Humans with Swine Contact, and Humans with No Swine Contact. | Hau SJ, Sun J, Davies PR, Frana TS, Nicholson TL. | PLoS One | 10.1371/journal.pone.0142832 | 2015 | |
| Metabolism | Proteomic and transcriptomic profiling of Staphylococcus aureus surface LPXTG-proteins: correlation with agr genotypes and adherence phenotypes. | Ythier M, Resch G, Waridel P, Panchaud A, Gfeller A, Majcherczyk P, Quadroni M, Moreillon P. | Mol Cell Proteomics | 10.1074/mcp.m111.014191 | 2012 | |
| Quinoline Functionalized Schiff Base Silver (I) Complexes: Interactions with Biomolecules and In Vitro Cytotoxicity, Antioxidant and Antimicrobial Activities. | Adeleke AA, Zamisa SJ, Islam MS, Olofinsan K, Salau VF, Mocktar C, Omondi B. | Molecules | 10.3390/molecules26051205 | 2021 | | |
| Metabolism | Cellular pharmacokinetics and intracellular activity of the novel peptide deformylase inhibitor GSK1322322 against Staphylococcus aureus laboratory and clinical strains with various resistance phenotypes: studies with human THP-1 monocytes and J774 murine macrophages. | Peyrusson F, Butler D, Tulkens PM, Van Bambeke F. | Antimicrob Agents Chemother | 10.1128/aac.00827-15 | 2015 | |
| Facile Synthesis of Antimicrobial Aloe Vera-"Smart" Triiodide-PVP Biomaterials. | Edis Z, Bloukh SH. | Biomimetics (Basel) | 10.3390/biomimetics5030045 | 2020 | | |
| Pathogenicity | Detection and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates in Canada: results from the Canadian Nosocomial Infection Surveillance Program, 1995-2006. | Adam HJ, Louie L, Watt C, Gravel D, Bryce E, Loeb M, Matlow A, McGeer A, Mulvey MR, Simor AE, Canadian Nosocomial Infection Surveillance Program. | Antimicrob Agents Chemother | 10.1128/aac.01316-09 | 2010 | |
| A novel IgY-Aptamer hybrid system for cost-effective detection of SEB and its evaluation on food and clinical samples. | Mudili V, Makam SS, Sundararaj N, Siddaiah C, Gupta VK, Rao PVL. | Sci Rep | 10.1038/srep15151 | 2015 | | |
| Pathogenicity | Reduced vancomycin susceptibility found in methicillin-resistant and methicillin-sensitive Staphylococcus aureus clinical isolates in Northeast China. | Hu J, Ma XX, Tian Y, Pang L, Cui LZ, Shang H. | PLoS One | 10.1371/journal.pone.0073300 | 2013 | |
| Enzymology | A microfluidic chip integrating DNA extraction and real-time PCR for the detection of bacteria in saliva. | Oblath EA, Henley WH, Alarie JP, Ramsey JM. | Lab Chip | 10.1039/c3lc40961a | 2013 | |
| Pathogenicity | In vitro and in vivo activities of linezolid alone and combined with vancomycin and imipenem against Staphylococcus aureus with reduced susceptibility to glycopeptides. | Ribes S, Pachon-Ibanez ME, Dominguez MA, Fernandez R, Tubau F, Ariza J, Gudiol F, Cabellos C. | Eur J Clin Microbiol Infect Dis | 10.1007/s10096-010-1007-y | 2010 | |
| Pathogenicity | In vitro and in vivo profiles of ACH-702, an isothiazoloquinolone, against bacterial pathogens. | Pucci MJ, Podos SD, Thanassi JA, Leggio MJ, Bradbury BJ, Deshpande M. | Antimicrob Agents Chemother | 10.1128/aac.01666-10 | 2011 | |
| Metabolism | Identification of Secreted Exoproteome Fingerprints of Highly-Virulent and Non-Virulent Staphylococcus aureus Strains. | Bonar E, Wojcik I, Jankowska U, Kedracka-Krok S, Bukowski M, Polakowska K, Lis MW, Kosecka-Strojek M, Sabat AJ, Dubin G, Friedrich AW, Miedzobrodzki J, Dubin A, Wladyka B. | Front Cell Infect Microbiol | 10.3389/fcimb.2016.00051 | 2016 | |
| Pathogenicity | A 1,000-Year-Old Antimicrobial Remedy with Antistaphylococcal Activity. | Harrison F, Roberts AE, Gabrilska R, Rumbaugh KP, Lee C, Diggle SP. | mBio | 10.1128/mbio.01129-15 | 2015 | |
| Pathogenicity | Vancomycin heteroresistance in bloodstream isolates of Staphylococcus capitis. | D'mello D, Daley AJ, Rahman MS, Qu Y, Garland S, Pearce C, Deighton MA. | J Clin Microbiol | 10.1128/jcm.00592-08 | 2008 | |
| Enzymology | Performance of various testing methodologies for detection of heteroresistant vancomycin-intermediate Staphylococcus aureus in bloodstream isolates. | van Hal SJ, Wehrhahn MC, Barbagiannakos T, Mercer J, Chen D, Paterson DL, Gosbell IB. | J Clin Microbiol | 10.1128/jcm.02302-10 | 2011 | |
| Syntheses and biological studies of novel spiropiperazinyl oxazolidinone antibacterial agents using a spirocyclic diene derived acylnitroso Diels-Alder reaction. | Ji C, Lin W, Moraski GC, Thanassi JA, Pucci MJ, Franzblau SG, Mollmann U, Miller MJ. | Bioorg Med Chem | 10.1016/j.bmc.2012.04.026 | 2012 | | |
| Genetics | An association between bacterial genotype combined with a high-vancomycin minimum inhibitory concentration and risk of endocarditis in methicillin-resistant Staphylococcus aureus bloodstream infection. | Miller CE, Batra R, Cooper BS, Patel AK, Klein J, Otter JA, Kypraios T, French GL, Tosas O, Edgeworth JD. | Clin Infect Dis | 10.1093/cid/cir858 | 2012 | |
| Mutacin 1140 Lantibiotic Variants Are Efficacious Against Clostridium difficile Infection. | Kers JA, Sharp RE, Defusco AW, Park JH, Xu J, Pulse ME, Weiss WJ, Handfield M. | Front Microbiol | 10.3389/fmicb.2018.00415 | 2018 | | |
| Bacteriocin-Antimicrobial Synergy: A Medical and Food Perspective. | Mathur H, Field D, Rea MC, Cotter PD, Hill C, Ross RP. | Front Microbiol | 10.3389/fmicb.2017.01205 | 2017 | | |
| Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphatase. | Lv W, Banerjee B, Molland KL, Seleem MN, Ghafoor A, Hamed MI, Wan B, Franzblau SG, Mesecar AD, Cushman M. | Bioorg Med Chem | 10.1016/j.bmc.2013.11.011 | 2014 | | |
| Pathogenicity | The first vancomycin-intermediate Staphylococcus aureus strains isolated from patients in Thailand. | Lulitanond A, Engchanil C, Chaimanee P, Vorachit M, Ito T, Hiramatsu K. | J Clin Microbiol | 10.1128/jcm.01749-08 | 2009 | |
| Phenotypic and Genotypic Characterization of Staphylococcus aureus Strains from Italian Dairy Products. | Morandi S, Brasca M, Andrighetto C, Lombardi A, Lodi R. | Int J Microbiol | 10.1155/2009/501362 | 2009 | | |
| Phylogeny | SmaI restriction site-based multiplex PCR for typing of hospital- and community-acquired Staphylococcus aureus. | Al-Zahrani IA, Hamson C, Edge D, Collins J, Perry JD, Raza M, Gould K, Harwood CR. | J Clin Microbiol | 10.1128/jcm.00857-11 | 2011 | |
| Enzymology | Clinical characteristics, outcomes, and microbiologic features associated with methicillin-resistant Staphylococcus aureus bacteremia in pediatric patients treated with vancomycin. | Welsh KJ, Abbott AN, Lewis EM, Gardiner JM, Kruzel MC, Lewis CT, Mohr JF, Wanger A, Armitige LY. | J Clin Microbiol | 10.1128/jcm.01949-09 | 2010 | |
| One-step syntheses of nitrofuranyl benzimidazoles that are active against multidrug-resistant bacteria. | Moraski GC, Thanassi JA, Podos SD, Pucci MJ, Miller MJ. | J Antibiot (Tokyo) | 10.1038/ja.2011.67 | 2011 | | |
| Biotechnology | Diagnostic microarray for 14 water and foodborne pathogens using a flatbed scanner. | Srinivasan V, Stedtfeld RD, Tourlousse DM, Baushke SW, Xin Y, Miller SM, Pham T, Rouillard JM, Gulari E, Tiedje JM, Hashsham SA. | J Microbiol Methods | 10.1016/j.mimet.2017.04.009 | 2017 | |
| Pathogenicity | A synthetic antibiotic class overcoming bacterial multidrug resistance. | Mitcheltree MJ, Pisipati A, Syroegin EA, Silvestre KJ, Klepacki D, Mason JD, Terwilliger DW, Testolin G, Pote AR, Wu KJY, Ladley RP, Chatman K, Mankin AS, Polikanov YS, Myers AG. | Nature | 10.1038/s41586-021-04045-6 | 2021 | |
| Pathogenicity | Approaches for Mitigating Microbial Biofilm-Related Drug Resistance: A Focus on Micro- and Nanotechnologies. | Rao H, Choo S, Rajeswari Mahalingam SR, Adisuri DS, Madhavan P, Md Akim A, Chong PP. | Molecules | 10.3390/molecules26071870 | 2021 | |
| Diagnostic PCR analysis of the occurrence of methicillin and tetracycline resistance genes among Staphylococcus aureus isolates from phase 3 clinical trials of tigecycline for complicated skin and skin structure infections. | Jones CH, Tuckman M, Howe AY, Orlowski M, Mullen S, Chan K, Bradford PA. | Antimicrob Agents Chemother | 10.1128/aac.50.2.505-510.2006 | 2006 | | |
| Pathogenicity | In vitro activity of the new quinolone WCK 771 against staphylococci. | Jacobs MR, Bajaksouzian S, Windau A, Appelbaum PC, Patel MV, Gupte SV, Bhagwat SS, De Souza NJ, Khorakiwala HF. | Antimicrob Agents Chemother | 10.1128/aac.48.9.3338-3342.2004 | 2004 | |
| Phylogeny | Rapid Detection and Differentiation of Clinically Relevant Candida Species Simultaneously from Blood Culture by Use of a Novel Signal Amplification Approach. | Ao W, Klonoski J, Berlinghoff E, Jensen J, Afroz T, Munns D, Lindsey W, Denys G, Jenison R. | J Clin Microbiol | 10.1128/jcm.00982-17 | 2018 | |
| Rationale-based, de novo design of dehydrophenylalanine-containing antibiotic peptides and systematic modification in sequence for enhanced potency. | Pathak S, Chauhan VS. | Antimicrob Agents Chemother | 10.1128/aac.01493-10 | 2011 | | |
| Pathogenicity | Investigation of reduced susceptibility to glycopeptides among methicillin-resistant Staphylococcus aureus isolates from patients in Ireland and evaluation of agar screening methods for detection of heterogeneously glycopeptide-intermediate S. aureus. | Fitzgibbon MM, Rossney AS, O'Connell B. | J Clin Microbiol | 10.1128/jcm.00836-07 | 2007 | |
| Pathogenicity | Antimicrobial activity of geranium oil against clinical strains of Staphylococcus aureus. | Bigos M, Wasiela M, Kalemba D, Sienkiewicz M. | Molecules | 10.3390/molecules170910276 | 2012 | |
| Metabolism | A PBP 2 mutant devoid of the transpeptidase domain abolishes spermine-beta-lactam synergy in Staphylococcus aureus Mu50. | Yao X, Lu CD. | Antimicrob Agents Chemother | 10.1128/aac.05415-11 | 2012 | |
| Effects of cyclic lipodepsipeptide structural modulation on stability, antibacterial activity, and human cell toxicity. | Bionda N, Stawikowski M, Stawikowska R, Cudic M, Lopez-Vallejo F, Treitl D, Medina-Franco J, Cudic P. | ChemMedChem | 10.1002/cmdc.201200016 | 2012 | | |
| Pathogenicity | Global spread of three multidrug-resistant lineages of Staphylococcus epidermidis. | Lee JYH, Monk IR, Goncalves da Silva A, Seemann T, Chua KYL, Kearns A, Hill R, Woodford N, Bartels MD, Strommenger B, Laurent F, Dodemont M, Deplano A, Patel R, Larsen AR, Korman TM, Stinear TP, Howden BP. | Nat Microbiol | 10.1038/s41564-018-0230-7 | 2018 | |
| Pathogenicity | Telavancin disrupts the functional integrity of the bacterial membrane through targeted interaction with the cell wall precursor lipid II. | Lunde CS, Hartouni SR, Janc JW, Mammen M, Humphrey PP, Benton BM. | Antimicrob Agents Chemother | 10.1128/aac.01710-08 | 2009 | |
| Metabolism | Kinin receptor expression during Staphylococcus aureus infection. | Bengtson SH, Phagoo SB, Norrby-Teglund A, Pahlman L, Morgelin M, Zuraw BL, Leeb-Lundberg LM, Herwald H. | Blood | 10.1182/blood-2006-04-016444 | 2006 | |
| Dissemination of methicillin-resistant Staphylococcus aureus USA300 sequence type 8 lineage in Latin America. | Reyes J, Rincon S, Diaz L, Panesso D, Contreras GA, Zurita J, Carrillo C, Rizzi A, Guzman M, Adachi J, Chowdhury S, Murray BE, Arias CA. | Clin Infect Dis | 10.1086/648426 | 2009 | | |
| Countrywide molecular survey of methicillin-resistant Staphylococcus aureus strains in Poland. | Luczak-Kadlubowska A, Sulikowska A, Empel J, Piasecka A, Orczykowska M, Kozinska A, Hryniewicz W. | J Clin Microbiol | 10.1128/jcm.00869-08 | 2008 | | |
| Pathogenicity | A new antibiotic kills pathogens without detectable resistance. | Ling LL, Schneider T, Peoples AJ, Spoering AL, Engels I, Conlon BP, Mueller A, Schaberle TF, Hughes DE, Epstein S, Jones M, Lazarides L, Steadman VA, Cohen DR, Felix CR, Fetterman KA, Millett WP, Nitti AG, Zullo AM, Chen C, Lewis K. | Nature | 10.1038/nature14098 | 2015 | |
| Enzymology | Identification and characterization of inhibitors of bacterial enoyl-acyl carrier protein reductase. | Ling LL, Xian J, Ali S, Geng B, Fan J, Mills DM, Arvanites AC, Orgueira H, Ashwell MA, Carmel G, Xiang Y, Moir DT. | Antimicrob Agents Chemother | 10.1128/aac.48.5.1541-1547.2004 | 2004 | |
| Biotechnology | Antibiotics from Extremophilic Micromycetes. | Baranova AA, Alferova VA, Korshun VA, Tyurin AP. | Russ J Bioorg Chem | 10.1134/s1068162020060023 | 2020 | |
| Pathogenicity | Cyclic lipodepsipeptides: a new class of antibacterial agents in the battle against resistant bacteria. | Bionda N, Pitteloud JP, Cudic P. | Future Med Chem | 10.4155/fmc.13.86 | 2013 | |
| Enzymology | Crystal structures of wild-type and mutant methicillin-resistant Staphylococcus aureus dihydrofolate reductase reveal an alternate conformation of NADPH that may be linked to trimethoprim resistance. | Frey KM, Liu J, Lombardo MN, Bolstad DB, Wright DL, Anderson AC. | J Mol Biol | 10.1016/j.jmb.2009.02.045 | 2009 | |
| Genetics | Functional analysis of the first complete genome sequence of a multidrug resistant sequence type 2 Staphylococcus epidermidis. | Lee JYH, Monk IR, Pidot SJ, Singh S, Chua KYL, Seemann T, Stinear TP, Howden BP. | Microb Genom | 10.1099/mgen.0.000077 | 2016 | |
| Enzymology | Survey of wastewater indicators and human pathogen genomes in biosolids produced by class a and class B stabilization treatments. | Viau E, Peccia J. | Appl Environ Microbiol | 10.1128/aem.01331-08 | 2009 | |
| Pathogenicity | The use of BMP-2 coupled - Nanosilver-PLGA composite grafts to induce bone repair in grossly infected segmental defects. | Zheng Z, Yin W, Zara JN, Li W, Kwak J, Mamidi R, Lee M, Siu RK, Ngo R, Wang J, Carpenter D, Zhang X, Wu B, Ting K, Soo C. | Biomaterials | 10.1016/j.biomaterials.2010.08.041 | 2010 | |
| Pathogenicity | Pharmacokinetic/pharmacodynamic factors influencing emergence of resistance to linezolid in an in vitro model. | Boak LM, Li J, Rayner CR, Nation RL. | Antimicrob Agents Chemother | 10.1128/aac.01194-06 | 2007 | |
| Transcriptome | Prediction of RNA-binding proteins from primary sequence by a support vector machine approach. | Han LY, Cai CZ, Lo SL, Chung MC, Chen YZ. | RNA | 10.1261/rna.5890304 | 2004 | |
| Phylogeny | Characteristics of Staphylococcus aureus strains isolated in Poland in 1996 to 2004 that were deficient in species-specific proteins. | Luczak-Kadlubowska A, Krzyszton-Russjan J, Hryniewicz W. | J Clin Microbiol | 10.1128/jcm.01164-06 | 2006 | |
| Pathogenicity | High percentage of methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides in The Netherlands. | Van Griethuysen A, Van 't Veen A, Buiting A, Walsh T, Kluytmans J. | J Clin Microbiol | 10.1128/jcm.41.6.2487-2491.2003 | 2003 | |
| Validation and reproducibility assessment of tigecycline MIC determinations by Etest. | Bolmstrom A, Karlsson A, Engelhardt A, Ho P, Petersen PJ, Bradford PA, Jones CH. | J Clin Microbiol | 10.1128/jcm.00089-07 | 2007 | | |
| Traditional Uses, Phytochemistry, and Bioactivities of Cananga odorata (Ylang-Ylang). | Tan LT, Lee LH, Yin WF, Chan CK, Abdul Kadir H, Chan KG, Goh BH. | Evid Based Complement Alternat Med | 10.1155/2015/896314 | 2015 | | |
| Pathogenicity | Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. | Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML. | Clin Microbiol Rev | 10.1128/cmr.00042-09 | 2010 | |
| Phylogeny | First report of methicillin-resistant Staphylococcus aureus with reduced susceptibility to vancomycin in Thailand. | Trakulsomboon S, Danchaivijitr S, Rongrungruang Y, Dhiraputra C, Susaemgrat W, Ito T, Hiramatsu K. | J Clin Microbiol | 10.1128/jcm.39.2.591-595.2001 | 2001 | |
| Metabolism | The Genus Cladosporium: A Rich Source of Diverse and Bioactive Natural Compounds. | Salvatore MM, Andolfi A, Nicoletti R. | Molecules | 10.3390/molecules26133959 | 2021 | |
| Design and development of a field-deployable single-molecule detector (SMD) for the analysis of molecular markers. | Emory JM, Peng Z, Young B, Hupert ML, Rousselet A, Patterson D, Ellison B, Soper SA. | Analyst | 10.1039/c1an15658f | 2012 | | |
| Enzymology | A robotic DNA purification protocol and real-time PCR for the detection of Enterobacter sakazakii in powdered infant formulae. | Derzelle S, Dilasser F. | BMC Microbiol | 10.1186/1471-2180-6-100 | 2006 | |
| Metabolism | Sugar metabolism, an additional virulence factor in enterobacteria. | Le Bouguenec C, Schouler C. | Int J Med Microbiol | 10.1016/j.ijmm.2010.04.021 | 2011 | |
| Performance assessment of DNA fragment sizing by high-sensitivity flow cytometry and pulsed-field gel electrophoresis. | Ferris MM, Yan X, Habbersett RC, Shou Y, Lemanski CL, Jett JH, Yoshida TM, Marrone BL. | J Clin Microbiol | 10.1128/jcm.42.5.1965-1976.2004 | 2004 | | |
| Enzymology | Ligase detection reaction generation of reverse molecular beacons for near real-time analysis of bacterial pathogens using single-pair fluorescence resonance energy transfer and a cyclic olefin copolymer microfluidic chip. | Peng Z, Soper SA, Pingle MR, Barany F, Davis LM. | Anal Chem | 10.1021/ac101843n | 2010 | |
| Recent advances in the chemistry and biology of naturally occurring antibiotics. | Nicolaou KC, Chen JS, Edmonds DJ, Estrada AA. | Angew Chem Int Ed Engl | 10.1002/anie.200801695 | 2009 | | |
| Enzymology | In situ-synthesized virulence and marker gene biochip for detection of bacterial pathogens in water. | Miller SM, Tourlousse DM, Stedtfeld RD, Baushke SW, Herzog AB, Wick LM, Rouillard JM, Gulari E, Tiedje JM, Hashsham SA. | Appl Environ Microbiol | 10.1128/aem.01962-07 | 2008 | |
| Ticagrelor alters the membrane of Staphylococcus aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance. | Leeten K, Jacques N, Esquembre LA, Schneider DC, Straetener J, Henriksen C, Musumeci L, Putters F, Melo S, Sanchez-Lopez E, Giera M, Penoy N, Piel G, Verlaine O, Amoroso A, Joris B, Slavetinsky CJ, Goffin E, Pirotte B, Frees D, Brotz-Oesterhelt H, Lancellotti P, Oury C. | mBio | 10.1128/mbio.01322-24 | 2024 | | |
| Development of a dual fluorescent reporter system to identify inhibitors of Staphylococcus aureus virulence factors. | Tao Z, Ke K, Shi D, Zhu L. | Appl Environ Microbiol | 10.1128/aem.00978-23 | 2023 | | |
| Evaluation of Antibacterial Activity of Thiourea Derivative TD4 against Methicillin-Resistant Staphylococcus aureus via Destroying the NAD+/NADH Homeostasis. | Hou Y, Zhu S, Chen Y, Yu M, Liu Y, Li M. | Molecules | 10.3390/molecules28073219 | 2023 | | |
| Electrospun Membranes Loaded with Melanin Derived from Pecan Nutshell (Carya illinoinensis) Residues for Skin-Care Applications. | Garcia-Garcia M, Jaime-Ferrer JS, Medrano-Lango FN, Quintana-Rodriguez E, Campos-Garcia T, Rodriguez-Sevilla E, Orona-Tamayo D. | Membranes (Basel) | 10.3390/membranes15020044 | 2025 | | |
| Linearized teixobactin is inactive and after sequence enhancement, kills methicillin-resistant Staphylococcus aureus via a different mechanism. | Wu Q, Mishra B, Wang G. | Pept Sci (Hoboken) | 10.1002/pep2.24269 | 2022 | | |
| Genetics | In vivo competition and horizontal gene transfer among distinct Staphylococcus aureus lineages as major drivers for adaptational changes during long-term persistence in humans. | Langhanki L, Berger P, Treffon J, Catania F, Kahl BC, Mellmann A. | BMC Microbiol | 10.1186/s12866-018-1308-3 | 2018 | |
| Cloning, Expression and Characterization of NAD Kinase from Staphylococcus aureus Involved in the Formation of NADP (H): A Key Molecule in the Maintaining of Redox Status and Biofilm Formation. | Prasad UV, Vasu D, Gowtham RR, Pradeep CK, Swarupa V, Yeswanth S, Choudhary A, Sarma PVGK. | Adv Biomed Res | 10.4103/2277-9175.211833 | 2017 | | |
| Metabolism | Redox Sensing Modulates the Activity of the ComE Response Regulator of Streptococcus mutans. | Dhaked HPS, Cao L, Biswas I. | J Bacteriol | 10.1128/jb.00330-21 | 2021 | |
| Pathogenicity | Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature. | Hiramatsu K, Igarashi M, Morimoto Y, Baba T, Umekita M, Akamatsu Y. | Int J Antimicrob Agents | 10.1016/j.ijantimicag.2012.02.007 | 2012 | |
| Metabolism | [Antibacterial activity of rare Streptomyces species against clinical resistant bacteria]. | Boughachiche F, Reghioua S, Zerizer H, Boulahrouf A. | Ann Biol Clin (Paris) | 10.1684/abc.2012.0661 | 2012 | |
| Enzymology | Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach. | Garonzik SM, Lenhard JR, Forrest A, Holden PN, Bulitta JB, Tsuji BT. | PLoS One | 10.1371/journal.pone.0156131 | 2016 | |
| Enzymology | Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model. | Lubenko IY, Strukova EV, Smirnova MV, Vostrov SN, Portnoy YA, Zinner SH, Firsov AA. | J Antimicrob Chemother | 10.1093/jac/dkn288 | 2008 | |
| Cloning, expression and characterization of glucokinase gene involved in the glucose-6- phosphate formation in Staphylococcus aureus. | Lakshmi HP, Yeswanth S, Prasad UV, Vasu D, Swarupa V, Kumar PS, Narasu ML, Krishna Sarma PV. | Bioinformation | 10.6026/97320630009169 | 2013 | | |
| A Supramolecular Approach for Enhanced Antibacterial Activity and Extended Shelf-life of Fluoroquinolone Drugs with Cucurbit[7]uril. | El-Sheshtawy HS, Chatterjee S, Assaf KI, Shinde MN, Nau WM, Mohanty J. | Sci Rep | 10.1038/s41598-018-32312-6 | 2018 | | |
| Metabolism | Potential Antibacterial Targets in Bacterial Central Metabolism. | Haag NL, Velk KK, Wu C. | Int J Adv Life Sci | 2012 | | |
| Enzymology | Structural and Functional analysis of Staphylococcus aureus NADP-dependent IDH and its comparison with Bacterial and Human NADPdependent IDH. | Prasad UV, Swarupa V, Yeswanth S, Kumar PS, Kumar ES, Reddy KM, Kumar YN, Rani VJ, Chaudhary A, Sarma PV. | Bioinformation | 10.6026/97320630010081 | 2014 | |
| Pathogenicity | Modified PAP method to detect heteroresistance to vancomycin among methicillin resistant Staphylococcus aureus isolates at a tertiary care hospital. | Iyer RN, Hittinahalli V. | Indian J Med Microbiol | 10.4103/0255-0857.40537 | 2008 | |
| Dissemination of methicillin-resistant Staphylococcus aureus SCCmec type IV and SCCmec type V epidemic clones in a tertiary hospital: challenge to infection control. | Dhawan B, Rao C, Udo EE, Gadepalli R, Vishnubhatla S, Kapil A. | Epidemiol Infect | 10.1017/s095026881400065x | 2015 | | |
| Enzymology | Clinical Features, Outcomes, and Molecular Characteristics of Community- and Health Care-Associated Staphylococcus lugdunensis Infections. | Yeh CF, Chang SC, Cheng CW, Lin JF, Liu TP, Lu JJ. | J Clin Microbiol | 10.1128/jcm.00847-16 | 2016 | |
| Characterization of the biological anti-staphylococcal functionality of hUK-66 IgG1, a humanized monoclonal antibody as substantial component for an immunotherapeutic approach. | Oesterreich B, Lorenz B, Schmitter T, Kontermann R, Zenn M, Zimmermann B, Haake M, Lorenz U, Ohlsen K. | Hum Vaccin Immunother | 10.4161/hv.27692 | 2014 | | |
| Diversity of two-component systems: insights into the signal transduction mechanism by the Staphylococcus aureus two-component system GraSR. | Muzamal U, Gomez D, Kapadia F, Kapadia F, Golemi-Kotra D. | F1000Res | 10.12688/f1000research.5512.2 | 2014 | | |
| Enzymology | [Investigation of infective endocarditis clinical isolates of methicillin resistant Staphylococcus aureus non-responsive to vancomycin]. | Takayama Y, Yoshida K, Yamaguchi Y, Nonoyama M, Endo T, Sunakawa K. | Kansenshogaku Zasshi | 10.11150/kansenshogakuzasshi1970.75.473 | 2001 | |
| Enzymology | The Use of Commercially Available Alpha-Amylase Compounds to Inhibit and Remove Staphylococcus aureus Biofilms. | Craigen B, Dashiff A, Kadouri DE. | Open Microbiol J | 10.2174/1874285801105010021 | 2011 | |
| Pathogenicity | A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. | Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. | J Antimicrob Chemother | 10.1093/jac/47.4.399 | 2001 | |
| Molecular Characteristics of Disease-Causing and Commensal Staphylococcus lugdunensis Isolates from 2003 to 2013 at a Tertiary Hospital in Taiwan. | Yeh CF, Liu TP, Cheng CW, Chang SC, Lee MH, Lu JJ. | PLoS One | 10.1371/journal.pone.0134859 | 2015 | | |
| Pathogenicity | An investigation of the antimicrobial effects of linezolid on bacterial biofilms utilizing an in vitro pharmacokinetic model. | Gander S, Hayward K, Finch R. | J Antimicrob Chemother | 10.1093/jac/49.2.301 | 2002 | |
| Pathogenicity | In vitro activities of daptomycin, arbekacin, vancomycin, and gentamicin alone and/or in combination against glycopeptide intermediate-resistant Staphylococcus aureus in an infection model. | Akins RL, Rybak MJ. | Antimicrob Agents Chemother | 10.1128/aac.44.7.1925-1929.2000 | 2000 | |
| Host- and tissue-specific pathogenic traits of Staphylococcus aureus. | van Leeuwen WB, Melles DC, Alaidan A, Al-Ahdal M, Boelens HA, Snijders SV, Wertheim H, van Duijkeren E, Peeters JK, van der Spek PJ, Gorkink R, Simons G, Verbrugh HA, van Belkum A. | J Bacteriol | 10.1128/jb.187.13.4584-4591.2005 | 2005 | | |
| Pathogenicity | Evaluation of bactericidal activities of LY333328, vancomycin, teicoplanin, ampicillin-sulbactam, trovafloxacin, and RP59500 alone or in combination with rifampin or gentamicin against different strains of vancomycin-intermediate Staphylococcus aureus by time-kill curve methods. | Hershberger E, Aeschlimann JR, Moldovan T, Rybak MJ. | Antimicrob Agents Chemother | 10.1128/aac.43.3.717 | 1999 | |
| Classification analysis of dual nucleotides using dimension reduction. | Qi ZH, Wang JM, Qi XQ. | J Theor Biol | 10.1016/j.jtbi.2009.05.011 | 2009 | | |
| Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam. | Backo M, Gaenger E, Burkart A, Chai YL, Bayer AS. | Antimicrob Agents Chemother | 10.1128/aac.43.10.2565 | 1999 | | |
| Phylogeny | Methicillin-resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. | Werner G, Cuny C, Schmitz FJ, Witte W. | J Clin Microbiol | 10.1128/jcm.39.10.3586-3590.2001 | 2001 | |
| Phylogeny | Typing and antimicrobial susceptibilities of methicillin resistant Staphylococcus aureus (MRSA) strains isolated in a hospital in Korea. | Lee HJ, Suh JT, Kim YS, Lenz W, Bierbaum G, Schaal KP. | J Korean Med Sci | 10.3346/jkms.2001.16.4.381 | 2001 | |
| Enzymology | Purification, characterization, and identification of novel inhibitors of the beta-ketoacyl-acyl carrier protein synthase III (FabH) from Staphylococcus aureus. | He X, Reynolds KA. | Antimicrob Agents Chemother | 10.1128/aac.46.5.1310-1318.2002 | 2002 | |
| Mannose binding lectin plays a crucial role in innate immunity against yeast by enhanced complement activation and enhanced uptake of polymorphonuclear cells. | van Asbeck EC, Hoepelman AI, Scharringa J, Herpers BL, Verhoef J. | BMC Microbiol | 10.1186/1471-2180-8-229 | 2008 | | |
| Pathogenicity | Activities of LY333328 and vancomycin administered alone or in combination with gentamicin against three strains of vancomycin-intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection model. | Aeschlimann JR, Allen GP, Hershberger E, Rybak MJ. | Antimicrob Agents Chemother | 10.1128/aac.44.11.2991-2998.2000 | 2000 | |
| Antistaphylococcal activity of WCK 771, a tricyclic fluoroquinolone, in animal infection models. | Patel MV, De Souza NJ, Gupte SV, Jafri MA, Bhagwat SS, Chugh Y, Khorakiwala HF, Jacobs MR, Appelbaum PC. | Antimicrob Agents Chemother | 10.1128/aac.48.12.4754-4761.2004 | 2004 | | |
| Radical SAM-Mediated Methylation of Ribosomal RNA. | Stojkovic V, Fujimori DG. | Methods Enzymol | 10.1016/bs.mie.2015.03.002 | 2015 | | |
| Phylogeny | First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. | Palazzo IC, Araujo ML, Darini AL. | J Clin Microbiol | 10.1128/jcm.43.1.179-185.2005 | 2005 | |
| Synthesis, Crystal Structure, and Antibacterial Properties of Silver-Functionalized Low-Dimensional Layered Zirconium Phosphonates. | Nocchetti M, Donnadio A, Vischini E, Posati T, Albonetti C, Campoccia D, Arciola CR, Ravaioli S, Mariani V, Montanaro L, Vivani R | Inorg Chem | 10.1021/acs.inorgchem.1c03565 | 2022 | | |
| Anti-mutant efficacy of antibiotic combinations: in vitro model studies with linezolid and daptomycin. | Zinner SH, Alieva KN, Golikova MV, Strukova EN, Portnoy YA, Firsov AA | J Antimicrob Chemother | 10.1093/jac/dkab095 | 2021 | | |
| Executing a Series of Zinc(II) Complexes of Homologous Schiff Base Ligands for a Comparative Analysis on Hydrolytic, Antioxidant, and Antibacterial Activities. | Chowdhury T, Dasgupta S, Khatua S, Acharya K, Das D | ACS Appl Bio Mater | 10.1021/acsabm.0c00372 | 2020 | | |
| The Killing Mechanism of Teixobactin against Methicillin-Resistant Staphylococcus aureus: an Untargeted Metabolomics Study. | Hussein M, Karas JA, Schneider-Futschik EK, Chen F, Swarbrick J, Paulin OKA, Hoyer D, Baker M, Zhu Y, Li J, Velkov T | mSystems | 10.1128/mSystems.00077-20 | 2020 | | |
| Metabolism | Cunninghamella blakesleeana-mediated biotransformation of a contraceptive drug, desogestrel, and anti-MDR-Staphylococcus aureus activity of its metabolites. | Atia-Tul-Wahab, Siddiqui M, Ibrahim I, Hussain A, Ajandouz EH, Hijazi A, Baydoun E, Choudhary MI | Bioorg Chem | 10.1016/j.bioorg.2017.12.027 | 2018 | |
| Pathogenicity | Testing the mutant selection window hypothesis with Staphylococcus aureus exposed to linezolid in an in vitro dynamic model. | Firsov AA, Alieva KN, Strukova EN, Golikova MV, Portnoy YA, Dovzhenko SA, Kobrin MB, Romanov AV, Edelstein MV, Zinner SH | J Antimicrob Chemother | 10.1093/jac/dkx249 | 2017 | |
| Transcriptomic Analysis of the Activity of a Novel Polymyxin against Staphylococcus aureus. | Zhao J, Cheah SE, Roberts KD, Nation RL, Thompson PE, Velkov T, Du Z, Johnson MD, Li J | mSphere | 10.1128/mSphere.00119-16 | 2016 | | |
| Pathogenicity | Metabolites from the Fungal Endophyte Aspergillus austroafricanus in Axenic Culture and in Fungal-Bacterial Mixed Cultures. | Ebrahim W, El-Neketi M, Lewald LI, Orfali RS, Lin W, Rehberg N, Kalscheuer R, Daletos G, Proksch P | J Nat Prod | 10.1021/acs.jnatprod.5b00975 | 2016 | |
| Pathogenicity | Synergy of beta-Lactams with Vancomycin against Methicillin-Resistant Staphylococcus aureus: Correlation of Disk Diffusion and Checkerboard Methods. | Sy CL, Huang TS, Chen CS, Chen YS, Tsai HC, Wann SR, Wu KS, Chen JK, Lee SS, Liu YC | J Clin Microbiol | 10.1128/JCM.01779-15 | 2015 | |
| Pathogenicity | Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus. | Bakar NS, Zin NM, Basri DF | Pak J Pharm Sci | 2012 | | |
| Pathogenicity | Biological evaluation of isothiazoloquinolones containing aromatic heterocycles at the 7-position: In vitro activity of a series of potent antibacterial agents that are effective against methicillin-resistant Staphylococcus aureus. | Wiles JA, Song Y, Wang Q, Lucien E, Hashimoto A, Cheng J, Marlor CW, Ou Y, Podos SD, Thanassi JA, Thoma CL, Deshpande M, Pucci MJ, Bradbury BJ | Bioorg Med Chem Lett | 10.1016/j.bmcl.2005.11.064 | 2005 | |
| Transcriptome | Burkholderia paludis sp. nov., an Antibiotic-Siderophore Producing Novel Burkholderia cepacia Complex Species, Isolated from Malaysian Tropical Peat Swamp Soil. | Ong KS, Aw YK, Lee LH, Yule CM, Cheow YL, Lee SM. | Front Microbiol | 10.3389/fmicb.2016.02046 | 2016 | |
| Newly Isolated Paenibacillus tyrfis sp. nov., from Malaysian Tropical Peat Swamp Soil with Broad Spectrum Antimicrobial Activity. | Aw YK, Ong KS, Lee LH, Cheow YL, Yule CM, Lee SM. | Front Microbiol | 10.3389/fmicb.2016.00219 | 2016 | |
How to citeIf you want to cite this particular strain cite the following doi:
https://doi.org/10.13145/bacdive138353.20260601.11
When using BacDive for research please cite the following paper
BacDive in 2025: the core database for prokaryotic strain data
License